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Cytokines, oncogenes, etc.
Interleukin.1 induced IL-8 generation in mesangial cells involves a
pertussis-toxin-sensitive guanine nucleotide binding component. Z.
Brown, R.M. Strieter, L.D. Fairbanks, G.H. Neild, S.L. Kunkel, J.
Westwick, Department of Pharmacology, University of Bath, CIa verton
Down, Bath; Department of Pathology, University of Michigan, Ann
Arbor, Michigan, USA; Department of Nephrology, Instutite of Urol-
ogy, London, United Kingdom. We have recently demonstrated that
human glomerular mesangial cells (MC) in vitro produce both IL-6, a
potent mitogenic cytokine and IL-8, a specific and potent chemotactic
peptide in response to the pro-inflammatory cytokines interleukin-1
(IL-la) and tumor necrosis factor (TNF) but not to LPS. Furthermore,
dexamethasone treatment of MC before stimulation with cytokines
resulted in a weak inhibition of both the expression of IL-8 mRNA and
release of IL-8 peptide. The present study was designed to investigate
the mechanism of the IL-I signal transduction involved in the regulation
of MC IL-8 and IL-6 generation. Submaximal concentrations of either
IL-In (3 ng/ml) or TNFa (300 ng/ml), were added to growth arrested,
confluent MC cultures for 18 to 20 hours, following treatment of the
cells with either vehicle, pertussis toxin (1 to 500 ng/ml), cholera toxin
(ito 100 ngIml) or the B-oligomer of pertussis toxin (ito 1000 ng/ml) for
5 hours. Extracellular concentrations of IL-8 and IL-6 were quantitated
by enzyme-linked immunoadsorbent assay (ELISA) and immunoradio-
metric assay (IMRIA), respectively. Expression of IL-8 and IL-6
mRNA was determined by Northern blot analysis. Pertussis toxin
treatment produced a dose related inhibition of IL-la but not TNFa
induced IL-8 generation. Furthermore, pertussis toxin did not modify
the IL-6 generation induced by either cytokine. Interestingly, pertussis
toxin treatment did not inhibit IL-8 mRNA expression in response to
IL-la. The B-oligomer of pertussis toxin, which has no ADP-ribosyl-
transferase activity, did not modify either the IL-I induced expression
of IL-8 mRNA nor did it alter the release of IL-8 peptide. In marked
contrast cholera toxin produced a 50 to 100% enhancement of IL-8 and
IL-6 generation induced by either cytokine. However, cholera toxin did
not significantly alter IL-8 mRNA expression in response to IL-la.
These results suggest that IL-la, but not TNFa, induced IL-8 genera-
tion in mesangial cells may involve a post-transcriptional pertussis
toxin-sensitive component.
Endothelin increases cytosolic calcium in human and rat polymorpho-
nuclear leukocytes. Inhibition by L-arginine. A. López-Farré, A. Riesco,
M. Moliz, G. Espinosa, J. Egido, S. Casado, L. Hernando, C.
Caramelo, Laboratorio de Nefrologla, Fundación Jiménez DIaz,
Madrid, Spain. The vasoconstrictor peptide, endothelin (ET), may be a
messenger not only towards the vascular smooth muscle side of the
endothelium but also towards the blood cells. The objective of the
present study was therefore to examine the effect of ET on a particular
group of blood cells, polymorphonuclear leukocytes (PMN). ET pro-
duced a dose-related [Ca2] peak in PMN from normal humans (l0 M
ET: [Ca2]1 214 52.9 nM; P < 0.001 with respect to baseline) and
control Wistar rats PMN (A [Ca2J1 119 15.3 nti; P < 0.05 with
respect to baseline). The ET-induced [Ca2] transient appeared to
come mostly from intracellular stores (inhibition of ET-induced Ca2
peak 98.2 5.3% with io M TMB-8, P < 0,05). Preincubation of
PMN in the presence of the nitric oxide-donor amino acid, L-arginine
(L-Arg, 60 mm, IO M), markedly blocked the ET-induced Ca2-
transient (78.04 7.01%, P < 0.005). This effect was specific for the
L-form of the amino acid, since l0— M D-Arg did not cause any
inhibition. When PMN were activated with the chemotactic peptide,
fMLP (l0 M), a similar blunting effect of L-Arg on fMLP-induced
[Ca2*] transient was detected. Further experiments were done to
examine the possible functional consequences of the aforementioned
findings. Neither ET nor L-Arg induced changes in the superoxide
anion release by human PMN. In addition, L-Arg did not affect the
fMLP-induced superoxide anion production. Further experiments were
carried out in conscious, unrestricted Wistar rats, to ascertain the in
vivo significance of the aforementioned findings. Systemic injection of
ET by carotid artery provoked an increase in circulating PMN. How-
ever, when ET was administrated by the femoral artery (local admin-
istration) we observed a decrease of 36.4 9.9% (P < 0.01) in the
circulating PMN within I mm. L-Arg (5 mg/kg body wt) increased the
circulating PMN in both local and systemic administration. Our results
support the view that ET has a potential role in activating PMN, an
effect that can be inhibited by L-Arg. Both these activating and
inhibitory effects may be involved in the pathogenesis of ischemia-
reperfusion injury in several organs.
Nuclear binding of murine monoclonal anti-DNA antibodies to mesan-
gial cells in vitro. B. Ciman, M.H. Foster, M.P. Madaio, Renal
Electrolyte Section, University of Pennsylvania, School of Medicine,
Philadelphia, Pennsylvania, USA. After administration of monoclonal
(M) lupus anti-DNA antibodies (Ab), derived from MRL-lpr/lpr mice, to
normal mice, a subgroup produced intranuclear deposits, in vivo. This
was associated with glomerular hypercellularity, epithelial foot process
fusion, fiber bundle formation within the mesangium (suggestive of new
collagen synthesis) and proteinuria. To further investigate the mecha-
nism of this phenomenon, we examined the interactions of these MAb
with glomerular cells in vitro. For this purpose, the mesangial cells were
isolated from the glomeruli of MRL mice and then established in
long-term culture by transformation with a nonreplicating, non-capsid
forming SV-40 virus. Following short-term culture of MAb H7, H9 and
H72 (previously demonstrated to produce intranuclear staining in vivo)
with the mesangial cells, intranuclear binding was observed. Cross
linking the cells with periodate-lysine prior to fixation did not affect the
intranuclear binding. Cytoplasmic staining was also found with the
monoclonal anti-DNA antibody, H72. By contrast nuclear staining was
not observed with either anti-DNA antibodies that did not produce
nuclear deposits in vivo, or antibodies that did not bind to DNA. These
studies establish an in vitro model system to evaluate the mechanisms
and consequences of anti-DNA antibody penetration into glomerular
mesangial cells.
Rat IgG enhances the production of IL-6 by rat renal mesangial cells.
M.E.A. van den Dobbeisteen, F.J. van der Woude, M.C. Krol, L.A.
van Es, MR. Daha, Department of Nephrology, University Hospital
Leiden, Leiden, Netherlands. The mesangium plays an important role
in processes of inflammation in the glomerulus. Previous studies
suggest that mesangial cells (MC) express Fc-gamma receptors and that
they are activated by immune complexes, resulting in secretion of
superoxide. It is also known that MC are able to produce IL-6 and IL-I.
These cytokines may function as autocrine growth factors. Since
immune complexes of various size maybe involved in inflammation, we
have investigated the effect of soluble aggregates of lgG (AIgG) on MC.
After 24 hours of culture resting MC produced less than 1 to 5 U
IL-6/l04 cells. A more than 10-fold increase was observed in response
to treatment of MC with AIgG. The specificity of this enhancement was
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studied by incubating the MC with Fc parts of rat lgG; the AIgG-
stimulated IL-6 release was reduced by 70%. F(ab)2 fragments were not
able to inhibit this response. IL-6 production could be blocked with
cyclohexamide which implies de novo synthesis of IL-6. Size fraction-
ation by HPLC indicated a size of 40 to 45 kD for rat IL-6. In agreement
with the functional data, fluorescent AIgG bound to the MC. This
binding could also be blocked with monomeric IgG. Additional studies
are in progress to determine whether MC are able to internalize and
degrade the immune aggregates which are bound to their surface.
Mesangial cells (MCs) in culture express smooth muscle a-actin. M.
Elger, R. Nobiling, D. Drenckhahn, W. Kriz, Departments ofAnatomy
and Physiology, Universities of Heidelberg and Wurzburg, Germany. It
is widely assumed that MCs actively contribute to the regulation of the
glomerular filtration rate, because of their contractile ability observed in
culture. However, the relevance of mesangial contraction is under
debate. To characterize the actin content of MCs a monoclonal anti-
body against smooth muscle a-actin (sm a-actin), an isoform present in
high amount in vascular smooth muscle cells (VSMCs), was used. The
occurrence of sm a-actin was studied in native cryostate section and
aldehyde-fixed I zm sections of kidneys and in cultured MCs by
indirect immunofluorescence. In sections of the kidney, the antibody
against sm a-actin intensely labelled the VSMCs of arteries, arterioles,
and descending vasa recta. Glomerular cells including MCs were not
reactive. A faint reactivity of a few cells was observed in the wall of the
intraglomerular segment of the efferent arteriole. By TEM these cells
were identified as smooth muscle cells. In contrast, MCs in culture
showed bright fluorescence in 50 to 90% of the cells treated with anti-sm
a-actin. The high percentage of positive cells was found in primary
cultures and up to ten investigated passages. In conclusion, MCs in
culture—in contrast to those in vivo—express sm a-actin. It seems
likely that the expression of this actin isoform accounts for their ability
of isotonic contraction.
Transforming growth factor 3 (TGF-/3) induces bimodal effects on
mesangial cell (MC) proliferation. U. Haberstroh, G. Zahner, F. Thaiss,
W. Schoeppe, R.A.K. Stahl, Department of Medicine, Division of
Nephrology, University of Frankfurt, Germany. In experimental gb-
merulonephritis expression of TGF-/3 and PDGF/3-receptor (PDGFBR)
mRNAs have been reported. TGF-3 might play a role in glomerular
disease due to effects on matrix accumulation and on cell growth. With
respect to the possible role on cell growth, inhibitory as well as
proliferative effects depending on the cell type, have been reported. In
some cells the effects of TGF-/3 have been proposed to be indirect due
to influences primarily on the PDGF loop. To study which role TGF-/3
might have on MC growth, and whether possible effects are interrelated
with the PDGF loop, we studied the effect of the polypeptide on cell
proliferation and the expression of the PDGFBR mRNA in rat MCs in
culture. Rat MCs were utilized after multiple passages, and were
cultured in DMEM with 10% FCS. Cells were growth arrested in 0%
FCS for 24 hours and then incubated with TGF-/3 (I ng/ml) for 20 mm.
Cells were kept on DMEM without serum. Cell growth was assessed at
24 and 48 hours by cell counting or 3H-thymidine incorporation. To
assess expression of PDGFBR mRNA, total RNA was extracted with
phenol-chloroform after cell lysis. Twenty g total RNA was separated
by electrophoresis and blots were hybridized with a t32P] labelled 2,8 kB
cDNA of the human PDGFBR. TGF-/3 (1 ng/ml) induced a significant (P
< 0.05) reduction of DNA synthesis at 24 hours (723 34 cpm/5000
cells) compared to controls (1879 164 cpm/5000 cells). At 48 hours,
cells treated with TGF-j3, however, incorporated almost 5 times more
3H-thymidine (8500 279) than corresponding control cells (1419
113). Expression of PDGFRB mRNA was unaffected at 24 hours, but
was increased at 48 hours following treatment of cells with TGF-/3.
These studies indicate that TGF-/3 inhibits and stimulates mesangial cell
growth in culture in a bimodal, time dependent fashion. A possible
mechanism might be the interrelation with the PDGF loop.
Proteinkinase C isoforms and growth response of vascular smooth
muscle cells. H. Hal/er, M. Buhl, C. Lindschau, A. Distler, Department
of Nephroiogy, K/inikum Steglitz, Free University, Berlin, Germany.
Protein kinase C (PKC) plays an important role in cellular growth and
differentiation. PKC exists as a family of different isoforms derived
from distinct genes, but little is known about the specific roles of the
isozymes in cell growth. In the present study we investigated (I) PKC
activity and the expression of the PKC isoforms a, /3 and yin vascular
smooth muscle cells (VSMC) from rat aorta after exposure to PDGF
(100 ng/ml) and angiotensin H (Ang II) (10 M). and (2) compared the
PKC isoform expression in rapidly proliferating VSMC from hyperten-
sive rats (SHR) with VSMC from normotensive animals (WKY). VSMC
proliferation was measured by thymidine incorporation. PKC activity
was measured by histone phosphorylation. PKC isoforms were as-
sessed by immunoblot using polyclonal antibodies for PKC isoforms a,
/3 and y. Exposure of the cells to PDGF and Ang II induced a rapid
activation of PKC within minutes. Longer exposure of the VSMC led to
a 3- to 6-fold increase in total PKC activity after 2 and 6 hours.
Immunoblot analysis showed an increased expression of PKC-/3 and -y
while PKC-a was unaltered. When we assessed PKC activity in VSMC
from SHR and WKY we did not find a significant difference in PKC
activity. Immunoblot analysis, however, revealed a down regulation of
PKC-/3 in SHR. This down regulation was also present in subcultured
VSMC from SHR and was positively correlated to the enhanced
proliferation of VSMC from SHR as compared to WKY. Our results
show that growth factors (PDGF) and trophic hormones (Ang II) rapidly
activate PKC in VSMC. A prolonged exposure to PDGF and Ang II
induces an increased expression of PKC-13 and -y. The time course of
the increased expression suggests a translational effect of the growth
factors. In contrast to these observations, the increased proliferation of
VSMC from SHR compared to WKY rats is associated with low levels
of PKC.j3. These findings argue for a role of PKC-/3 in VSMC-
proliferation and suggest a bifunctional effect of PKC-f3 in cell growth
and response to growth factors.
Interferon gamma modulates adhesion of PMN to cytokine-activated
endothelium. R. Hallmann, M.A. Jutila, N. Ehsani, E. Amento, E.G.
Butcher, K. Von der Mark, Max-Planck-Arbeiisgruppen f. Rheumatol-
ogie, Erlangen, Germany; Genentech, South San Francisco, Califor-
nia; Department of Pathology, Stanford School of Medicine, Stanford,
California; Veterinary Res. Laboratory, Montana State University,
Bozeman, Montana. The adhesion of leukocytes to the endothelium of
the blood vessel wall is a crucial step in the process of leukocyte
extravasation into an inflamed tissue. Cultured human umbilical vein
endothelial cells (HUVEC) have been utilized as a model cell for
studying leukocyte adhesion to endothelium in vitro. HUVEC can be
activated with the cytokines IL-I, TNF or with lipopolysaccharide
(LPS) to bind polymorphonuclear granulocytes (PMN), monocytes and
lymphocytes. The activation results in the expression of cell adhesion
molecules on the cell surface. It has been described that ICAM-l is
upregulated on activated HUVEC and other adhesion molecules, like
ELAM-l and VCAM, are newly expressed on the HUVEC cell surface.
Another activating cytokine, Interferon gamma, has been described to
have diverse effects on endothelial cells, We show here that pretreat-
ment of HUVEC with Interferon gamma followed by stimulation of the
endothelial cells with IL-I, TNF or LPS promotes lymphocyte adhesion
but inhibits PMN adhesion. The loss of PMN-adhesion caused by the
Interferon pretreatment is not due to a quantitative change in adhesion
molecule numbers on the endothelial cell surface as evaluated by FACS
analysis. It has previously been shown that IL-8 inhibits PM N-adhesion
to HUVEC. This cytokine can be produced by HUVEC and has been
shown to act directly on PMN. Consequently, we investigated IL-8
secretion by HUVEC and found that treatment with Interferon gamma
did not stimulate the HUVEC to secrete detectable levels of IL-8.
Furthermore, anti-IL-8 antibodies did not affect the changes described
above. The results suggest that the selective adhesion of lymphocytes,
monocytes or PMN may be regulated by different combinations of
cytokines altering the pattern of adhesion molecules on the endothe-
hum. This may be manifested as a conformational change in known
adhesion molecules or as unique expression of activation-specific
molecules still awaiting our identification.
The glomerular mesangium: Cellular origin and cell-type specific
markers in vivo and in vitro. H. Holthafer, K. Sainio, A. Miettinen,
Department of Bacteriology and immunology, and of Pathology,
University of Helsinki, Helsinki, Finland. We have searched for cell
surface, intracellular or cell matrix markers for the identification of
glomerular mesangial cells in viva and in vitro, and used these to study
the appearance of mesangial elements during differentiation of rat
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kidney glomeruli. Presence of major matrix components, laminin,
fibronectin, type IV collagen and heparan sulphate proteoglycans was
observed in rat kidney mesangial cells in vivo and in vitro using indirect
immunofluorescence microscopy, confirming previous results. Simi-
larly, antibodies against NC-I and MI of type IV collagen, and A, B!
and B2 chains of laminin decorated mesangial matrix in vivo and in cell
culture. Interestingly, thrombospondin was found exclusively in the
Bowman's capsules, and cellular fibronectin only in mesangium of
tissue sections, but both were seen on cultured mesangial cells. On the
other hand, the alpha I chain of integrin was strictly localized in the
mesangium, whereas other integrin alpha chains were also found in
other glomerular cells. Although bone marrow derivation of some
mesangial cells has been proposed, we failed to see any positivity with
various markers of rat monocytes/macrophages in cultured cells. Other
antibody markers applied included antibodies to intermediate filaments,
and smooth muscle-specific molecules, as well as for various neuropep-
tides and neural components. Of these, only desmin, smooth muscle
myosin and Thy 1.1 were typically found in cultured mesangial cells, as
well as in vivo. In vitro, induced 13d rat embryonic mesenchymes
cultured for 4 days, showing glomeruloid bodies and without vascular
elements, failed to show antigens typical for mesangial cells, whereas
embryonic rat kidneys at various differentiation stages showed mesan-
gial epitopes, which appeared in parallel with vascular elements. These
results suggest that a panel of antibodies, including those against Thy
1.1, cellular fibronectin, smooth muscle myosin, integrin alpha 1 chains
and desmin, accurately identify glomerular mesangiuni and cells con-
sidered to be mesangial in culture. Furthermore, these results suggest
that the glomerular mesangium is derived from invasion, similarly to
vascular endothelials cells, presumably from outside vessels, support-
ing the view that mesangial cells represent specialized pericytes.
Endothelium mediated inhibition of mesangial cell growth is flow
dependent. M. Morigi, C. Zoja, M. Figliuzzi, G. Remuzzi, and A.
Remuzzi, Mario Negri Institute for Pharmacological Research, Ber-
gamo, Italy, We investigated the effects of endothelial cell exposure to
hemodynamic shear forces on the modulation of mesangial cell growth
in culture. Confluent monolayers of bovine aortic endothelial cells
(BAEC) were incubated for 24 hours with medium containing 10% fetal
calf serum (FCS) under laminar or static flow condition. The prolifer-
ation of bovine mesangial cells studied as 3H-thimidine uptake was
comparable after incubation with medium alone (containing 10% FCS)
and with culture medium from BAEC under static flow (57,667 16,925
vs. 50,565 11,299 cpm). In contrast, when mesangial cells were
incubated with medium from BAEC exposed to laminar flow, 3H-
thymidine uptake by mesangial cells was significantly (P < 0.01)
inhibited (2,257 1,996). These data show that supernatants of BAEC
exposed to laminar flow almost completely abolish proliferation of
mesangial cells in culture. These findings suggest that local glomerular
capillary blood flow may modulate the proliferation of mesangial cells
that is often associated with glomerular damage.
Mesangial cell proliferation factor(s) differing from IL-i and IL-6
produced by cultured human monocytes. T. Morioka, I. Narita, F.
Shimizu, and T. Oite, Department of immunology, Institute of Nephrol-
ogy, Niigalta University School of Medicine, Niigata, Japan. Mono-
cytes products have been found to possess mesangial cell growth
stimulating activity, one of these products being biochemically similar
to interleukin-1. Monocytes may quite likely produce other growth
regulatory factors associated with mesangial cell proliferation. In this
study, conditioned media from LPS-treated human peripheral blood
leukocytes induced a marked increase in the 3H-thymidine incorpora-
tion of mesangial cells cultured in a low serum concentration. Two
monocyte-derived mesangial proliferation factors (MDF) differing in
size were separated by gel filtration. They eluted in a fraction different
from that of thymocytes proliferating activity. The addition of anti-
human-IL-I or anti-recombinant human IL-6 antibody did not inhibit
the mitogenic effect of both MDFs. Addition of anti-human PDGF
antibody decreased the mitogenic effect of the lower molecular weight
MDF but not the higher molecular MDF. From these data, we conclude
that: 1) a large portion of the monocyte-derived mesangial cell growth
factor was not IL-I nor 11-6, but PDGF or PDGF-like molecule; and 2)
there is an unknown mesangial cell proliferating factor, or factors
besides IL-I, IL-6 and PDGF.
IGF-1 induced tyrosine phosphorylation of c-jun oncoprotein. B.S.
Oemar, N. Law, and S.A. Rosenzweig, Children's Hospital, Hannover
Medical School, Hannover, Germany and Departments of Cell Biology
and Ophthalmology, Yale University School of Medicine, New Haven,
Connecticut, USA. Upon binding to its specific cell-surface receptors,
IGF-I initiates multiple cellular responses including mitogenic effects,
genes expression and cell differentiation. These effects implicate an
activation of trans-acting factors located in the nucleus, which increase
and/or suppress transcription of gene in response to IGF-I receptor
activation. Tyrosine phosphorylation of protein kinases is thought to
play a major role in signal transmission by IGF-l receptors to the
nucleus. However, the target of IGF-I receptor tyrosine kinase activa-
tion in the nucleus has not yet been determined. Using immunoprecip-
itation in intact cells and immunofluorescence labelling with a poly-
clonal antibody specific for phosphotyrosine, we now show that IGF-I
induces a rapid phosphorylation of c-jun oncoprotein on tyrosyl resi-
dues. Our previous studies have shown that diabetic mouse (db/db)
mesangial cells express high levels of IGF-l receptor. Stimulation of 32P
labelled db/db cells with IO M IGF-I and subsequent immunoprecip-
itation shows a rapid tyrosine phosphorylation of both IGF-I receptor
p-subunit and a 185 kDa protein in a dose and time dependent manner.
Parallel to this, immunoprecipitation of the nuclear extract revealed a
rapid phosphorylation on tyrosine residues of a —43 kDa protein with a
maximal stimulation within I nun. Confocal laser scanning microscopy
of fluorescently labelled db/db cells with the anti-phosphotyrosine
antibody confirmed the nuclear localization of this phosphoprotein.
Maximal intensity of the labelling occurred within I mm, consistent
with the immunoprecipitation results. After 30 mm the phosphorylation
of this nuclear protein returned to basal levels. Sequential immunopre-
cipitation of the nuclear extract of IGF-l stimulated db/db cells with
anti-phosphotyrosine antibody, followed by anti-c-jun antibody, re-
vealed a rapid and transient tyrosyl phosphorylation of c-jun oncopro-
tein. Again the maximal stimulation was achieved within I mm,
gradually decreasing over time, and returning to basal levels 30 mm
after stimulation. These results indicate that one target of IGF-I
receptor activation is the transcription factor c-jun. This finding may
contribute to a better understanding of the signal transduction pathway
of tyrosine kinase type growth factor receptors.
Modulation of nitric oxide (NO) synthase by cytokines and anti-
inflammatory steroids in rat renal mesangial cells (MC). J. Pfeilschifter,
A. Mülsch, K. Vosbeck, and R. Busse, Ciba-Geigy Ltd, Research
Department, Pharmaceuticals Division, Basel, Switzerland, and insti-
tute ofApplied Physiology, University of Freiburg, Freiburg, Germany.
Treatment of MC with interleukin 1/3 (IL- 1/3) or tumor necrosis factor a
(TNFa) has been shown to increase cGMP formation, most probably
due to induction of NO synthase. Treatment of MC with actinomycin D,
cycloheximide or anti-inflammatory steroids completely abolished cy-
tokine-induced cGMP formation. N°-monomethyl-L-arginine was a
potent inhibitor of cytokine-induced cGMP formation, while N°-nitro-
L-arginine was less active. Transforming growth factor /32 (TGF/32)
dose-dependently inhibited IL-ip- and TNFa-stimulated cOMP forma-
tion in MC. Half-maximal inhibition was observed at concentrations of
0.4 and 0.06 ng/ml of TGF/32, respectively. Formation of NO was
detected in the cytosol of cytokmne-treated MC by activation of purified
soluble guanylate cyclase, and depended on tetrahydrobiopterin, but
not on Ca2-calmodulin. Conditioned medium from IL-I/3-treated MC
increased cGMP in untreated control cells. The present data suggest
that IL-1/3 and TNFa induce the macrophage-type of NO synthase in
MC and thereby may alter the contractile responsiveness of the cells.
Anti-mesangial cell antibodies detected with ELISA method in IgA
mesangial nephropathy (IgAGN). C. Pinerolo, P. Bernasconi, A. For-
nasieri, S. Armelloni, L. Mm, G. Fellin, A. Gibelli, G. D'Amico,
Division of Nephrology and Immunohematology Service, San Carlo
Hospital, Milano, Italy. The presence of circulating IgG antibodies (Ab)
against human glomerular antigens (Ag) in IgA-GN was recently
reported. In the present study, we investigated the possible presence of
Ab directed against constituents of mesangial cells in IgA-GN and
Henoch-SchOnlein syndrome (SH). Pure mesangial cells were obtained
from primary cultures of normal human glomeruli, and were character-
ized by morphological and phenotypic analysis. The antigen extract was
prepared by sonication of mesangial cells between the 3rd and 5th
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passage. The Ag was then coated on plastic plates at concentrations of
20 g/ml and sera tested with solid-phase ELISA. Patient and control
sera were incubated for 2 hrs at 37°C and the reaction was revealed by
peroxidase-conjugated goat anti-human IgG or IgA. We tested sera
from 84 patients with lgA-GN, 11 with SH, 86 normal controls, and 17
patients with various types of primary glomerulonephritis (9 membra-
nous GN, 4 acute post-infectious GN, 4 membranoproliferative GN
type I). Twenty-two of 84 patients (26%) with lgA-GN, and 7/11 with
SH were positive for Ab of the IgG class. In the control group, 2 cases
of acute post-infectious GN were also positive. IgA Ab were always
negative. The specificity of reaction was checked by a fluid phase
inhibition test. The possible interference of anti-fibronectin Ab was
excluded because increasing doses of fibronectin did not inhibit the
binding. Correlations with the main clinical and serological data were
also investigated. Significant correlations were found with the presence
of gross hematuria (P = 0.029; likelihood ratio chi-square) and IgA
immune complexes (P = 0.021). Our data suggest the presence of IgG
Ab against mesangial cell antigens in IgA-GN. Further studies are
required to assess these findings' significance, role in glomerular
damage, and utility in disease monitoring.
interleukin-6 secreted by human glomerular mesangial cells (HMC).
H.H. Radeke, C. Mittermair, A. Emmendorffer, R. Schindler, K.
Resch, Molecular Pharmacology, Nephrology, Medical School, Fraun-
hofer Institute, Hannover, Germany. Rat mesangial cells have been
shown to secrete interleukin-6 (lL-6) activity, which in turn serves as an
autocrine growth factor. Also in humans urinary IL-6 excretion was
observed in patients with MPGN. We have shown that the basal release
of IL-6 bioactivity (7TDI) by cultured HMC could be induced by
IL-l-a/f3> PDGF-BB > TNF-a//3> endotoxin> IFN-gamma. Com-
binations with PDGF-BB or TNF-&f3 led to additive effects. By
Northern blot analysis we demonstrated that IL-l-/3 also increased
basal IL-6 RNA expression by HMC. However, a highly sensitive TL-6
ELISA (<5 pg monocytic IL-6) failed to measure immunoreactive IL-6
in HMC supernatants. In order to characterize HMC derived IL-6 we
performed Western blots with a goat-anti-human monocyte IL-6 anti-
body. SDS-PAGE of rh lL-6 and human monocyte supernatants
showed bands at 2 1/23 kDa and 26/31 kDa. Using HMC supernatants we
detected 43/47 kDa bands. Furthermore, whereas five separate antibod-
ies from different sources effectively inhibited the bioactivity of rh IL-6
and monocyte IL-6, HMC lL-6 bioactivity was not neutralized. These
data suggest that HMC secrete an IL-6 isoform, which in contrast to rh
lL-6 might have an autocrine effect on HMC proliferation.
Effects of tumor necrosis factor (TNF) on cultured rat mesangial cell
(CRMC) contraction. M. Rodriguez-Puyol, J. Medina, J.A. Gila, D.
Rodriguez-Puyol, L. Baud, Universi dad de Alcala de Henares, Spain,
and INSERM, Unite'64, H. Tenon, Paris, France. Although there is
some evidence pointing to a possible contractile effect of TNF on
CRMC, the hemodynamic effects of TNF do not support this finding.
Thus, we tested the ability of TNF to contract CRMC, trying to analyze
the differences between the intrinsic effect, and the effect in the
presence of Angiotensin II (Ang II). TNF induced a clear reduction of
planar cell surface area (PSCA) of CRMC in a dose-dependent manner
(C: 100 2%, TNF 100 ng/ml: 70 l%*, TNF 10 ng/ml: 82 4%*, *p
< 0.05 vs. C. Results are percent of PCSA with respect to the initial
PCSA, after 30 mm incubation at room temperature) and time-depen-
dent (Time 0: 100%. Time 10 mm: 87 4%* Time 20 mm: 76 5%*
Time 30 mm: 69 5%* *D < 0.05 vs. 0. Results are percent of PCSA
with respect to the initial PCSA, with TNF 100 ng/ml at room temper-
ature). Moreover, TNF increased 32P incorporated into a protein which
comigrated with a myosin light chain standard on SDS-PAGE by 73%
(from 12.1 2.3 to 20.9 1.5* cpm/pg, N = 2, 8p <0.05). TNF at 100
ng/ml also increased the effect of Ang 1110-8 M on PCSA of CRMC
(Ang II: 78 6%. All + TNF: 65 2%*, *p < 0.05 vs. Ang II. Results
are percent of PCSA with respect to the initial PCSA, after 60 mm at
room temperature, adding the TNF 30 mm after Ang II), and did not
prevent the Ang 11-related contraction of CRMC. These results suggest
that TNF could modify renal function by decreasing the renal plasma
flow or the ultrafiltration coefficient.
Role of protein kinase C in the induction of Egr-1 mRNA in rat
mesangial cells by PDGF and AVP. H.D. Rupprecht, V.P. Sukhatme,
RB. Sterzel, D.L. Coleman, Yale University School of Med. (VAMC),
West Haven, Connecticut; Department of Medicine, University of
Chicago, Chicago, Illinois, USA; Med. Klinik IV, University of Erlan-
gen-Nurenberg, Germany. The early growth response gene I (Egr-1) is
a member of the group of immediate early response genes which are
induced by mitogenic and differentiation signals. The 5-untranslated
region of the Egr-1 gene contains several potential binding sites for
transcriptional regulatory factors. Five serum response elements, two
AP-I binding sites (TPA-response elements), four SP-1 binding sites
and two cAMP response elements have been identified within I kb
upstream of the transcription start site. Egr-1 mRNA expression is
induced by protein kinase C (PK-C) dependent as well as PK-C
independent pathways. The gene encodes a protein which binds DNA
through "zinc finger" domains and activates transcription of other
genes. In view of the role of PK-C in inducing Egr-l mRNA and its
possible role in transmitting mitogenic signals in mesangial cells (MC's),
we investigated the role of PK-C in mediating the effects of platelet
derived growth factor (PDGF) and arginine-vasopressin (AVP) on Egr-l
in MCs. MCs were used between passages 5 and 11 and were serum
starved for three days before assaying. An increase in Egr-1 mRNA was
detected as early as 15 minutes after addition of PDGF(5 ng/ml) or AVP
(108 M). The amount of transcript peaked between 45 and 60 minutes
and stayed elevated for at least 4 hours. Both PDGF and AVP induced
a dose-dependent increase of Egr-l mRNA in a range of 0.1 to 10 ng/ml
and l02 to io— M, respectively. The doses of AVP and PDGF
required to induce Egr-l mRNA were similar to those required to
induce proliferation. To investigate the role of PK-C in induction of
Egr-l mRNA, PK-C activity was down regulated by treatment of the
cells with 12-O-tetradecanoylphorbol 13-acetate (TPA, 500 nM) for 48
hours. Chronic TPA-treatment of MC's for 48 hours was sufficient to
fully abrogate the induction of Egr-l mRNA by freshly added TPA,
confirming the blockade of the PK-C pathway. Down regulation of
PK-C did not affect the induction of Egr-l mRNA by PDGF. In
contrast, however, the Egr-1 response to AVP in PK-C depleted cells
was markedly diminished. Maximum Egr-l mRNA increase over base-
line was 4.9-fold in PK-C down regulated cells compared to 6.6-fold in
control cells (densitometric measurement). Egr-l levels returned to
baseline by 120 minutes in PK-C depleted cells, but stayed elevated in
control cells for up to 8 hours. The proliferative response of MCs to
AVP was also partly PK-C dependent. in control cells, AVP induced a
5.9-fold increase in 3H-thymidine incorporation, whereas in PK-C down
regulated cells only a 1.9-fold increase was observed. These results
demonstrate that induction of Egr-l mRNA and proliferative response
to PDGF and AVP are tightly correlated. AVP induces Egr-l mRNA
and proliferation through PK-C dependent and independent pathways.
PDGF, however, acts solely through PK-C independent pathways.
Extracellular adenosine triphosphate (ATP) stimulates proliferation
and PGE2—production of cultured rat mesangial cells (MCs) via P2-
receptors. E. Schulze-Lohoff, S. Zanner, A. Ogilvie, and R.B. Sterzel,
University of Erlangen-Nurnberg, Erlungen-Nurnberg, Germany.
Platelet products play a significant role in glomerulonephritis. Since
ATP is stored and secreted by platelets in high concentrations, we
tested the hypothesis, that extracellular ATP might influence rat MC
proliferation and secretion of PGE2 in culture. Addition of ATP (10—100
M) to the medium increased DNA replication (3H-TdR uptake) of
resting MCs 2.35-fold (N = 19) after 48 hr. MC counts increased by
44—46%. Of the non-hydrolysable ATP analogues, ATPyS was most
potent in stimulating DNA synthesis (6.16-fold, N = 5), indicating
involvement of P2w-receptors. In combination with PDGF-AB or IL-1$,
extracellular ATP had synergistic mitogenic activity. PGE2 secretion,
measured in resting MCs after stimulation with ATP, increased 9.l6-
fold within 5 mm and 11.1-fold by 8 hr. This effect was dose dependent
(10—500 sM) and due to P2, receptor stimulation, as judged by different
effects of various ATP analogues. We conclude that extracellular ATP
could play a significant role in glomerular inflammation by stimulating
MC proliferation and PGE2 secretion via specific receptors.
Effect of cell density on growth regulation of human glomerular
epithelial cells in culture. M. Späth, H. Pavenstadt, T. Kirste, C.
Wanner. P. Schollmeyer, Medizinische Universitätsklinik, Abteilung
Innere Medizin IV, Freiburg, Germany. Glomerular epithelial cells
(GEC) play an important role in the development of focal glomerular
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sclerosis. A variety of growth factors and the local cellular environment
take part in growth regulation and development of GEC. To understand
whether responsiveness of GEC to growth factors might be modulated
by cell density, we investigated the influence of epidermal growth factor
(EGF) on cell proliferation as well as the role of transforming growth
factor beta (TGF/3) on growth modulation in human visceral GEC in
culture plated at different cell densities. Proliferation of cells was
determined by [3H]thymidine incorporation. EGF exhibited a dose-
dependent stimulation independent from cell density in culture. Addi-
tion of TGFf3 in concentrations greater than 0. 1 nglml to cells prestim-
ulated with EGF (1 ng/ml) and plated at densities 18,000 and 50,000 cells
per cm2 was followed by a significant growth inhibition. In contrast,
cells plated at 5,000 cells per cm2 were not inhibited by TGF/3 in this
concentration range (0.1 and 1.0 nglml). Moreover, concentrations of
TGF/3 up to I ng/ml resulted in an additional, but not significant,
increase of EGF-induced proliferation. This synergistic effect could be
further enhanced by higher EGF concentrations. In summary, these
experiments clearly demonstrate a significant effect of cell density on
responsiveness of human visceral GEC in culture to TGFj3.
The autocrine, antimitogenic effect of atrial natriuretic factor (ANF) in
aortic smooth muscle cells (SMC) is mediated by ANF B-receptors. C.
Westenfelder, E.H. Welcer, and R.L. Baranowski, University of Utah
& VA Medical Centers, Salt Lake City, Utah, USA. We demonstrated
that cultured rat aortic SMCs (<5 passages) contained ANF (99—126)
(>2 ngIlO6 cells), Pro-ANF and ANF specific mRNA. This confirmed
that aortic SMCs synthesize authentic ANF. In addition, cultured
SMCs secreted (>3 ng148 hrs/106 cells) of ANF(99—l26), whereas
neither endotheljal nor mesangial cells expressed or secreted ANF.
These data demonstrate that aortic SMCs are a source of ANF and
suggest that this ANF may have an autocrine function within the
vascular wall. We explored, therefore, whether ANF(99-.l26) could
modulate the mitogenic response of cultured rat aortic SMCs. Quies-
cent (no fetal calf serum for 48 hrs), subconfluent cultures of aortic
SMCs and glomerular mesangial cells (MSC) were stimulated with 10%
fetal calf serum in the presence of ANF(99—126) (lOh1 to 10_s M). In
aortic SMCs lO M ANF inhibited [3H] thymidine incorporation by 57
5% (P < 0.001) and in MSCs by 55 8% (P < 0.001). Since SMCs
possess both guanylyl cyclase coupled (B) and clearance" (C) recep-
tors, we examined which receptor type mediates the antimitogenic
effect of ANF. We found that 10 M 8 Br-cGMP, a permeable cGMP
analog and second messenger for ANF, inhibited mitogenesis by >50%
both in SMCs and MSCs. Exposure of cells to a truncated analog of
ANF (binds to C-receptors) failed to inhibit mitogenesis. These data
demonstrate that ANF's antimitotic action is mediated by ANF B-re-
ceptors and suggest that ANF, derived from SMCs, may have auto- and
paracnne effects that may be vasoprotective in hypertension and
arteriosclerosis. In addition, ANF may modulate MSC proliferation in
glomerulonephritis.
The localization of interleukin-1$ (IL-1f3) mRNA by in situ hybridiza-
tion in human kidney after hemorrhage. D.A.S. Jenkins, D.R. Woy-
tacha, S. Fleming, A.D. Cumming, Medical Renal Unit, University
Department of Medicine and University Department of Pathology,
Edinburgh Royal Infirmary, Edinburgh, United Kingdom. Hemorrhage
is a potent stimulus to the production of cytokines, and IL-1/3 is
produced early in the acute phase response to injury by a wide variety
of cell types. In addition to acting as an inflammatory mediator, IL-lp
may be involved in the renal functional response to injury. Using in situ
hybridization, we investigated the distribution of lL-lp mRNA in the
kidney of a 24-year-old woman, who had undergone nephrectomy
following traumatic renal hemorrhage secondary to a road traffic
accident. There was no history of renal disease before or after the
event. Tissue was fixed in formalin and embedded in paraffin. A Pstl
restriction fragment of an IL-1/.3 eDNA probe in PTZ 19R vector
(Courtesy Dr D. Carter, Upjohn Laboratory) was P32-labelled by the
random primer technique. Radiolabelled probe was hybridized to tissue
sections after de-waxing and proteinase-K treatment. IL-1/3 mRNA was
expressed in both cortex and medulla, in glomeruli, proximal and distal
tubular cells. Vascular expression was prominent; signal was detected
in the media of both large and small arteries, and in endothelium of both
arteries and veins. Signal was also detected in intertubular spaces,
possibly in relation to peritubular capillaries. The abundance of IL-113
mRNA in these sections is compatible with a role for IL-l/3 in the renal
response to hemorrhage, with the potential to influence both renal
hemodynamics and tubular function.
The effect of arginine vasopressin (AVP) and oxytocin (OXT) on
vascular smooth muscle (VSMC), glomerular mesangial (GMC) and
myometrium cells (MMC) in culture. V.A. Briner, P. Tsai, R. W. Schrier,
Renal Division, U.C.H.S.C., Denver, Colorado, USA and Nephrology,
University-Hospital, Basel, Switzerland. AVP induces vasoconstric-
tion. OXT stimulates uterine contraction and may also promote an
antidiuresis. AVP and OXT are structurally similar peptides. The aim of
the study: I) to examine AVP and OXT effect on contraction in VSMC,
GMC, and MMC, 2) distinguish whether the OXT- or AVP-receptor
(rec) initiate the contraction in these 3 cell lines. AVP (10 M) induced
contraction in 50% of VSMC (P < 0.01) and 33% of GMC (P < 0.01).
These effects were blocked by Vl-AVP antagonist (ant) but not
OXT-ant. AVP (l0- M) stimulated contraction in MMC (50%; P <
0.01). This effect was attenuated by VI-ant. OXT (lO_6 M) induced
contraction of VSMC (43%), GMC (16%) and MMC (40%). OXT was
less potent than AVP. The effect of OXT on GMC and VSMC was
blocked by V 1-ant but not OXT-ant. OXT effect on MMC was reduced
by OXT-ant (P < 0.01). With all 3 cell liens contraction was associated
with 43Ca2 efilux and 3H-AVP binding studies revealed a single class of
AVP-rec. Conclusion: 1) AVP induces contraction in VSMC, GMC and
MMC by a Vl-rec; 2) high doses of OXT occupy this VI-rec in VSMC
and GMC and cause contraction; 3) in MMC OXT effect is mediated by
an OXT-rec.
Effects of native and oxidized low density lipoprotein (LDL) particles on
human mesangial cell growth and viability in vitro. D.C. Wheeler, R.S.
Chana, N. Topley, M. Davies, J.D. Williams, Institute of Nephrology,
CardiffRoyal Infirmary, Cardf/ Wales, United Kingdom. Lipoproteins
play a key role in the pathogenesis of atherosclerosis and may also
contribute to glomerular injury. Oxidation of LDL is thought to occur
within the vascular intima and may enhance the atherogenicity of this
lipoprotein. Previous studies had shown that rat mesangial cells show a
biphasic proliferative response to increasing LDL concentration with
growth inhibition above 200 tg/ml (protein). To determine whether
oxidative modification of LDL might contribute to renal injury, human
mesangial cells were incubated for 24 hours with varying amounts of
both native and modified lipoprotein in vitro. Native LDL enhanced
3H-thymidine incorporation at concentrations less than 75 pg/mI (pro-
tein), but inhibited cell division when present in larger amounts. In
contrast, oxidized lipoprotein did not increase proliferation rate but
inhibited growth throughout the concentration range studied (up to 300
pg/mI), While the maximal proliferative effect of native LDL occurred
at 50 pg/mI, an equivalent concentration of oxidised lipoprotein caused
a 50% reduction in 3H-thymidine incorporation. At concentrations
greater than 100 pg/mI oxidized, but not native LDL, caused an
increase in the lactate dehydrogenase content of the medium suggesting
cell injury. Synthesis of prostaglandin E2, 6-keto-prostaglandin F1 and
thromboxane A2 was enhanced by addition of native LDL. Oxidized
lipoprotein caused a more dramatic dose-dependent increase in ei-
cosanoid synthesis despite its apparent cytotoxic effect. These results
help to strengthen the analogy between glomeruloscierosis and athero-
sclerosis and provide evidence that oxidative modification of LDL may
enhance the nephrotoxicity of this lipoprotein.
Epidermal growth factor receptors in IgA nephropathy. P. Roy-
Chaudhury, P. Grabowski, N.E. Haites, A.M. McLeod, and D,A.
Power, Department of Medicine and Therapeutics and Department of
Molecular and Cell Biology, University of Aberdeen, Aberdeen, Scot-
land, United Kingdom. IgA nephropathy is a common form of glomer-
ulonephritis characterized by mesangial cell proliferation. We have
shown that the epidermal growth factor receptor (EGF-R) is predomi-
nantly localized to mesangial cells within the human glomerulus and
that there is mesangial up regulation of this receptor in biopsies from
some patients with IgA nephropathy. The p185 neu receptor, which has
a 50% homology with the epidermal growth factor receptor, was,
however, absent from the glomerulus in both normal and diseased
kidneys. Our findings suggest that the epidermal growth factor receptor
is likely to play an important role in the pathogenesis of IgA nephrop-
athy. Despite its homology with the EGF-R, the p185 nell receptor is
unlikely to have similar importance. We are at present attempting to
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determine which cytokines up regulate EGF-R expression in cultured
human mesangial cells. We have also derived primers for the newest
member of the EGF-R family, HER-3, and will shortly determine
whether it is expressed in cultured mesangial cells using the polymerase
chain reaction.
Tumor necrosis factor-alpha and receptors for interleukin-2 in Wegen-
er's granulomatosis/microscopic polyarteritis. I.L. Noronha, M. Eber-
lein-Gonska, K. Andrassy, R. Waldherr, Departments of Pathology and
Internal Medicine, University of Heidelberg, Heidelberg, Germany. In
ANCA-positive systemic vasculitis (Wegener' s granulomatosis/micro-
scopic polyarteritis) tumor necrosis factor-alpha (TNFa) is supposed to
play an important role as mediator of the inflammatory reactions
promoting neutrophil degranulation and leading to activation of endo-
thelial cells. Receptors for interleukin 2 (IL-2R) are expressed after
immunological stimuli, and the interaction of IL-2 with its receptors is
fundamental for the action of IL-2 and subsequent clonal T-cell prolif-
eration. IL-2R are not only expressed on the cell membrane, but are
also released into the extracellular fluid. This soluble form of the IL-2R
(sIL-2R) can be measured in plasma samples. To assess the presence of
TNFa and IL-2R in systemic vasculitis, we determined these mediators
in kidney biopsies as well as in the plasma. Cryostate sections from 19
patients with systemic vasculitis were examined by immunocytochem-
istry (APAAP method) using monoclonal antibodies against TNFa
(Celltech CB0006) and IL-2R (Clonab Tu 69). The plasma levels of
TNFs and sIL-2R were assayed by means of an ELISA method (T-Cell
Sciences) at the time of biopsy. TNFa positive infiltrating mononuclear
cells were observed in 15/19 cases and IL-2R positive cells were
detected in 16/19 biopsies. TNFa and IL-2R positive cells were local-
ized in the interstitium, in cellular crescents as well as surrounding
blood vessels (arterioles, small arteries and veins). Infiltrating positive
cells were also detected in vessel walls of arteries/arterioles exhibiting
acute necrosis. With regard to TNFa determination in plasma samples,
normal individuals had consistently low TNFa levels, and in the
majority of the measurements it was undetectable (1.9 3.6 pg/mI;
mean so). Higher TNFa plasma levels were observed in patients with
vasculitis (58.1 98.31 pg/mI). When the ninety-five percent confidence
interval was calculated for the control group, plasma levels of TNFa
higher than 10 pg/mI were considered abnormal. By this definition, 7
patients showed elevated TNFa levels. All patients with vasculitis
presented a marked increase in sIL-2R plasma levels when compared to
normal controls (2602 361 U/mI vs. 361 133 U/mI; P < 0.001). The
number of TNFa and IL-2R positive cells in renal tissue correlated
neither with ANCA titers (cANCA/pANCA) nor with the plasma levels
at the time of biopsy. We conclude that TNFs and IL-2R is produced by
infiltrating cells in situ in systemic ANCA-positive vasculitis, and that
they may represent important mediators in the vasculitic process.
Inte grins, matrix, etc.
Early increased renal procollagen (PC) al (IV) mRNA levels in
steptozotocin-induced diabetes mellitus in the rat is insulin inhibitable and
of tubular origin. S.G. Adler, A. Artishevsky, C.G. Ihm, G.S.L. Lee,
CC. Nast, R. Guillermo, P.S.Anderson, R.J. Glassock, Department of
Medicine and Pathology, Harbor-UCLA Medical Center, Torrance,
California, USA. Whole kidney al (IV) levels are reportedly increased
in the diabetic mouse. In vitro, increased al (IV) levels and/or type IV
collagen synthesis occur in tubules, endothelial and mesangial cells
cultured in high glucose medium. We studied the origin of increased
renal al (IV) in rats with insulin treated (NPH) or untreated diabetes
(DM), compared to diluent injected controls (C) 7 or 28 days post-
diseaseinduction. In vitro hybridization studies, quantitated as % of the
mean control value, revealed significant increase only for medullary PC
al (IV) in DM:
Medulla
NPH DM C
PC aI(IV) 87 12 244 5T 100 12
PC al(I) 120 11 141 5 100 13
PC al(HI) — — —



















* P < 0.05 vs. C
In situ hybridization with cDNA and antisense cRNA localized the PC
al (IV) increment predominantly to proximal tubules in deep cortex and
outer medulla. Sense cRNA did not bind. In conclusion, tubular PC al
(IV) increases in DM prior to any significant change in glomerular
levels, and is inhibited by low dose insulin.
High glucose increases diacylglycerol mass and activates protein kinase
C in mesangial cell cultures: A possible mechanism for increased ECM
synthesis. S.H. Ayo, J.I. Kreisberg, Department of Pathology
UTHSCSA San Antonio, Texas, USA. High glucose (30 mM) stimulates
the synthesis and mRNA levels of the extracellular matrix (ECM)
proteins fibronectin, laminin and type IV collagen in mesangial cell
cultures. Treatment of mesangial cell cultures with RPMI 1640 contain-
ing 30 m glucose for 30 minutes resulted in a 3-fold increase in
diacyiglycerol (DAG) mass, as measured using the enzyme DAG
kinase, when compared to cells grown in control medium containing 10
m glucose. This increase in DAG mass was maintained through one
week. The degree of protein kinase C activation can be determined by
measuring the amount of activity in the soluble and particulate cellular
fractions. Activation is associated with the translocation of activity
from the cytosol to the particulate fraction. After 60 minutes of 30 mti
glucose, the activity associated with the particulate fraction was signif-
icantly increased. The distribution of protein kinase C between the two
fractions returned to control levels by 24 hours. Cells treated with the
cell permeable diacylglycerol analogue oleoyl acetyl glycerol (OAG) to
activate protein kinase C displayed increased levels of fibronectin,
laminin and type IV collagen mRNA while actin mRNA remained
unchanged. These data suggest a possible role for protein kinase C
activation in the measured increase od ECM mRNAs reported in high
glucose medium.
Development of glomerulosclerosis in murine chronic graft-versus-host
disease. The role of the extracellular matrix. E.C. Bergijk, C. Munaut,
J.J. Baelde, F. Prins, J.M. Foidart, P.J. Hoedemaeker, J.A. BruUn,
Department of Pathology, University of Leiden, Leiden, The Nether-
lands, and Department of Biology, University ofLiege, Liege, Belgium.
In the final stage the lupus type nephropathy in murine chronic
graft-versus-host disease (GvHD) results in the development of glomer-
uloscierosis. We investigated the development of glomei-ulosclerosis by
examining the distribution patterns of the extracellular matrix (ECM)
components laminin, fibronectin, collagen I, III, IV and VI during the
course of the disease, using immunofluorescence, immunoelectron
microscopy and reflection contrast microscopy. All ECM components
except collagen I were found in glomeruli of normal mice. They were all
intrinsic constituents of the mesangium. Laminin, fibronectin and
collagen IV were also situated in the glomerular capillary walls. Six
weeks after the induction of GvHD, expansion of the mesangial matrix
and thickening of the glomerular basement membrane with the forma-
tion of spikes was observed. The amount of larninin, fibronectin,
collagen IV and VI increased. Ten weeks after the onset of the disease,
glomerulosclerosis developed. Traces of the interstitial collagen I could
be found in sclerotic glomeruli. The presence of the ECM components
collagen III, IV, VI, and laminin was decreased dramatically in the
glomerular sclerotic lesions as compared to week 8. In contrast Ii-
bronectin showed a marked increase in the sclerotic lesions. By
immunoelectron microscopy laminin and collagen IV were found to be
located around the sclerotic lesions, in the remnants of mesangial
matrix and collapsed capillary walls. Fibronectin was also present in the
sclerotic lesions, probably due to increased production of fibronectin
and/or to accumulation of exogenous fibronectin in the damaged gb-
meruli. Early results suggested an increase in VLA-4, a /3-integrin
fibronectin receptor in the diseased glomeruli. Northern and slot blot
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analysis showed an increase in mRNA levels for al type I collagen, al
type IV collagen, and laminin B I and B2 in total kidney material prior
to morphological changes. The mRNA levels in isolated glomeruli at
week 8 were increased as compared to control levels. For al type IV
collagen, it was shown that the mRNA level in isolated glomeruli
decreased again at week 10. This is in agreement with the histological
change in collagen IV distribution in sclerotic glomeruli.
Tenascin synthesized by embryonic epithelia and peripheral glia accu-
mulates in the surrounding mesenchyme. M. Koch, S. Baum gartner, J.
Spring, D. Brubacher, B. Wehrle-Haller, M. Chiquet, Biozentrum der
Universitat, Abt. Biophys. Chemie, Base!, Switzerland. The extracel-
lular matrix protein, tenascin, has been proposed as mediator in
epithelial-mesenchymal interactions in the embryo. Tenascin accumu-
lates transiently in the dense mesenchyme surrounding growing epithe-
ha, such as, lung buds. The protein is also expressed temporarily in the
mesenchyme along peripheral nerve pathways. By in situ hybridization,
we studied the cellular origin of tenascin in these cases. Tenascin
mRNA was found to be accumulated exclusively by the bronchial
epithelium at sites of active ingrowth. In developing peripheral nerves,
tenascin mRNA is mainly produced by glial precursor cells. Thus, the
protein seems to be accumulated in the mesenchyme at sites distant
from its place of synthesis. Since tenascin can inhibit spreading of
mesenchymal cells, it could cause retraction of mesenchyme along
growing nerves and epithelia.
VLA al-a6 and aV integrins in glomerulonephritis. S. 1uié, R.
Wa!dherr, Departments of Pathology, Sveucilisna bolnica, Zagreb,
Yugoslavia, University of Heidelberg, Heidelberg, Germany. Integrins
are a family of cell surface proteins that are involved in cell-cell
adhesion and cell-extracellular matrix interactions. They are membrane
glycoproteins consisting of two noncovalently associated subunits, a
and /3. Oneclass of integrins is comprised of unique a chains complexed
to a common /31 chain. We examined normal kidney tissue and 40 renal
biopsies from patients with various forms of GN by immunocytochem-
istry (APAAP method) using monoclonal antibodies against al(VLAI)
(clone TS2/7), a2(VLA2)-CDw49b (clone Gi9), a3(VLA3)-CDw49c
(clone P1 B5), a4(VLA4)-CDw49d (clone HP2/l), a5(VLA5)-CDw49e
(clone SAM1), a6(VLA6)-CDw49f (clone GoH3) and a,,-CD5I (vit-
ronectin receptor, clone AMF7): IgA-GN (N = 10), membranous GN(N = 10), minimal change (N = 10), focal glomerulosclerosis (N = 5),
acute ON (N = 5). In normal kidneys (N = 5), mesangial cells were
VLA al-, VLA a2- and weakly VLA aS positive. Podocytes and
capsular epithelial cells expressed VLA al, VLA a3 and a,,. Glomer-
ular endothelial cells as well as endothelial and myointimal cells of
interstitial vessels were positive for VLA a3. All tubules showed a
marked staining for VLA a6 at the basal membrane junction. In
addition, distal tubules were positive for VLA a!, VLA a2, VLA a3
and a,,. Compared to normal kidneys, no change in the glomerular
staining pattern for VLA a2-a6 was observed in IgA-GN, acute GN,
and in the majority of cases with minimal change nephrotic syndrome.
In cases with mesangial enlargement VLA al expression was in-
creased. In membranous ON and focal glomerular sclerosis mesangial
cells showed a decreased reactivity for VLA a2 and/or VLA aS; in focal
glomeruloscierosis an additional decrease of VLA a! expression was
observed. In the majority of these biopsies, tubules were negative for
VLA a6. Reduced staining for a,, was observed in podocytes and distal
tubular epithelial cells in focal glomeruloscierosis and acute GN.
Cellular crescents in IgA-GN and acute GN were positive for VLA a!,
VLA a3 and a,,, fibroblasts in fibrocellular crescents expressed VLA
al, VLA a2, VLA aS and a,,. Sclerotic glomeruli and areas of
segmental glomerular sclerosis were completely negative. Interstitial
inflammatory mononuclear cells expressed VLA a4, and in addition, in
some cases of acute ON VLA aS. Our results demonstrate that there is
an altered expression of integrin receptors on glomerular cells and
tubular epithelial cells in some forms of glomerulonephritis. The mod-
ification of integrin expression may be important for the understanding
of cell-matrix interactions in these conditions.
The pathogenesis of interstitial fibrosis in chronic purine aminonucle-
oside nephrosis. A. Eddy, C. Jones, S. Bach, M. Post, L. McCulloch,
E. Liu, Divisions of Nephrology and Neonatology, The Hospital For
Sick Children, University of Toronto, Toronto, Ontario, Canada. The
pathogenesis of interstitial fibrosis which develops in chronic nephrotic
syndrome is unclear. In this study, the cellular and molecular mediators
of interstitial fibrosis were investigated using the chronic model of
purine aminonucleoside (PAN) nephrosis. Thirty experimental (PAN)
rats were given 15 mg/lOO g body weight i.p. on days 20, 27 and 34; 25
control rats received i.p. saline. All rats had a right nephrectomy within
the first four days. Groups of control and PAN rats were sacrificed at
21, 37, 52, 72 and 91 days. Renal sections were studied by immunoflu-
orescence to quantitate interstitial macrophages (MØ), T lymphocytes
and fibroblasts; to characterize the deposition of extracellular matrix
(ECM) proteins collagens I, III, and IV, fibronectin, laminin and the
tissue inhibitor of the metalloproteinases (TIMP). Steady state levels of
mRNA from the whole kidney were quantitated by Northern blotting
for these ECM proteins, the metalloproteinases, TIMP, and transform-
ing growth factor beta 1 (TGF-f31). Significant increases in the number
of interstitial MØ and T lymphocytes were found in all PAN groups. Mø
were the most numerous of these cells. All ECM proteins examined
were increased in the tubulointerstitium of PAN rats. The pattern of
distribution of some ECM proteins was also modified in PAN animals.
Fibronectin was found along the tubular basement membrane in PAN
but not in control rats; collagen IV and laminin were present in small
quantities in the interstitium of PAN but not control animals. TIMP was
increased in the sclerotic regions of glomeruli and in tubular protein
droplets. Northern blotting revealed increased steady state mRNA
levels for components of each of the ECM proteins, no change in
mRNA for the metalloproteinases stromelysin or collagenase, and a
marked increase in the mRNA for TIMP and TGF-13l in PAN animals.
The results of this study suggest that the diffuse interstitial fibrosis
found in chronic PAN nephrosis results from both increased production
of ECM proteins and decreased matrix degradation. TGF-/31, which
may be derived from infiltrating MØ or native renal cells, may be one of
the mediators of interstitial fibrosis.
Laminin and fibronectin support the organization of the basal pole of
renal epitbelial cells. S. Fleming, MA. Rahilly, Department of Pathol-
ogy, University of Edinburgh, Edinburgh, Scotland, United Kingdom.
The basal pole of renal epithelial cells is composed of alternating areas
of focal contact with the extracellular matrix and membrane infoldings.
This structural arrangement greatly increases the surface area of the
cells to facilitate molecular transport during filtration, secretion and
reabsorption. We have investigated the molecular basis of this organi-
zation in Vitro. Human renal epithelial cells were grown on glass
coverships or coverslips coated with laminin, fibronectin or collagen I.
The distribution of focal contacts was studied by immunofluorescent
demonstration of /31 integrins, vinculin, talin and actin. Cells grown on
glass or type I collagen show focal contacts at the cell periphery. By
contrast when grown on laminin or fibronectin focal contacts containing
vinculin and talin are distributed as linear arrays arranged on the entire
ventral surface of the cells. These focal contacts show reactivity for /31
integrin and a3, a5 and a6 integrin chains. The actin cytoskeleton also
becomes more organised in the cells grown on laminin or tibronectin.
We conclude that in vitro laminin and fibronectin can support the
structural differentiation of the basal pole of renal epithelium through
integrin and vinculin containing extracellular matrix contact regions.
Glomerular cell proliferation precedes matrix accumulation and scle-
rosis in the remnant kidney model. J. Floege, M. Burns, C.E. Alpers, P.
Pritzl, W.G. Couser, R.J. Johnson, Departments of Nephrology and
Pathology, University of Washington, Seattle, Washington, USA.
Early expansion of the mesangial matrix with subsequent glomerular
sclerosis is a characteristic feature of the remnant kidney model. To
investigate the chronology of events that precede sclerosis, biopsies
were obtained from rats at various times following 5/6 nephrectomy as
well as from sham-operated controls. The biopsies were stained with
PAS as well as immunostained for PCNA/cyclin (a cell proliferation
marker), collagen types I and IV, and for laminin. Glomerular sclerosis
indices (% of glomeruli with focal or global sclerosis) and immunohis-
tochemical staining scores for the matrix proteins (graded from 0 to 4)
were determined. Significant glomerular sclerosis was not detected until
3 weeks after 5/6 nephrectomy and then progressively worsened.
Immunohistochemical staining results (expressed as either mean posi-
tive cells per glomerular cross section for PCNA or glomerular score for
matrix proteins) were done. The data demonstrated that in the remnant
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kidney model glomerular accumulation of normal matrix proteins
(collagen IV, laminin) as well as de novo expression of collagen I
occurred prior to significant sclerotic changes. This matrix accumula-
tion was preceded by glomerular cell proliferation, raising the possibil-
ity that proliferation and matrix overproduction are causally related











Vasoactive substances modulate growth and protein synthesis of cul-
tured rat mesangial cells. A. Woithuis, A. Boes, H.P. Rodemann, J,J.
Weening, J. Grond, Department of Pathology, University of Gronin-
gen, The Netherlands and Department of Developmental Biology,
University of Bielefeld, Germany. In glomerular disease, MC prolifer-
ation and matrix expansion may be initiated and propagated by vaso-
active hormones, mediators from intrinsic glomerular cells, infiltrating
macrophages and platelets, or by altered cell-to-cell interaction as a
consequence of hypercellularity. In the present study, we explored the
phlogogenic potential of angiotensin II (Ang II), arginine vasopressin(AVP), and serotonin (5-HT) by examining their effects on growth
activity and protein biosynthesis of MCs in culture. Quiescent subcon-
fluent rat MCs (passage # 5 to 10) were exposed for 3 days to Ang II,
AVP, and 5-HT (l0 to 10-8 M in 0.5% FCS). Cellular proliferation
was assayed at day 3 by measuring 30-hr DNA synthesis (ELISA assay
of incorporated bromodeoxyuridine). AVP and 5-HT were clearly
mitogenic with maximal stimulation at 10-6 M, reaching 30 and 40%,
respectively, of the effect of 10% FCS. Ang II was not mitogenic. The
effects of these agents on matrix production were studied by sandwich
ELISA for fibronectin (FN) in cultures of different cell densities. FN
secreted into the medium (SeFN) and intralpericellular FN (CaFN)
were measured separately, the latter after solubilization of cells and
matrix layer. In all incubations (10 to 11 wells per experiment), negative
non-linear relationships were found between MC numbers (range 20 to
250 x l0 cells/2 cm2) and SeFN as well as CaFN. Logarithmic
transformation resulted in highly significant negative linear relation-
ships in all incubations (r values ranging from —0.9705 to —0.9947 for
SeFN and —0.9620 to —0.9944 for CaFN; P < 0.001). Thus, the
suppressing effects on FN production of increasing cell density is
independent of growth activity. It was of note that AVP significantly
increased SeFN (P < 0.5) and decreased CaFN (P < 0.001). Total
soluble cellular protein profiles were studied by metabolic labelling with
35 S methionine (18 hr, 200 rCi/ml medium) and 2-D electrophoresis of
cell lysates (IEF and SDS-PAGE, 15% polyacrylamide gels). This
resulted in resolution of >500 radiolabeled MC proteins in the p1 range
of 5 to 7.5. Computerized video densitometry of selected areas (molec-
ular wt range 20,000 to 90,000 and p1 5.5 to 6.5) revealed over!
underexpression of >10 different proteins. In conclusion, these studies
reveal profound modulatory effects of the vasoactive agents Ang II,
AVP, and 5-HT on growth and protein synthesis of rat MCs in culture.
Roles of VCAM-1/a4131 and LFA-I/ICAM-1 ligand pairs in leucocyte-
endothelial cell adhesion. l.A. Hauser, J.A. Madri, Pathology Depart-
ment, Yale University School of Medicine, New Haven, Connecticut,
USA. Vasculature exposed to inflammatory mediators induces an
increase of leucocyte and inflammatory cell adhesion, The increased
adhesion between leucocytes (L) and endothelial cells (EC) results from
leucocyte-dependent and endothelial cell-dependent mechanisms. We
investigated the role of the endothelial cell surface molecules ICAM-1
(intercellular cell adhesion molecule) and VCAM- I (vascular cell adhe-
sion molecule) on human EC and their ligands cx4131 and /32 integrins
(LFA, Mac) on U937 cells, a human histiocytoma monocyte-like cell
line. To assess possible differences between large vessel endothelia and
microvascular endothelia we used human iliac vein endothelial cell
cultures (HVC), representing large vessel endothelia and human kidney
microvasculature (H KEC) representing microvessel endothelia. The
human endothelial cell cultures were stimulated with TNFa (500 U!mI
media) for 24 hours and U937 cell adhesion was assayed. The prein-
cubation of EC with VCAM-1 and ICAM-l(Fav R6!5) mouse monoclo-
nal antibodies inhibited the TNFa stimulated adhesion to 90% and 30%,
respectively, in renal microvasculature and only to 30% and 25% in
human venous cells. The preincubation of U937 cells with an a4/31
mouse monoclonal antibody (163 H) inhibited the leucocyte endothelial
cell adhesion completely in HKEC, whereas mouse monoclonal anti-
bodies to /2 integrins showed only moderate inhibition. The presence of
ICAM-1 and VCAM-1 on EC was documented by immunoprecipitation
of endothelial cell lysates after cell surface labeling with 1125 or biotin.
ICAM-l was expressed on HKEC without stimulation and its expres-
sion was increased after TNFa stimulation with a maximum at 18 to 24
hours. ICAM-l was expressed very weakly in unstimulated HVC, but
was markedly increased after 24 hours of TNFa stimulation to maximal
levels comparable to those of renal microvasculature. VCAM-1 was
expressed on unstimulated HKEC at a baseline level, increased after 4
hours and decreased again after 24 hours. VCAM-l was not detectable
on HVC without or with TNFa stimulation. Our results indicate an
important role for the vascular cell adhesion molecule VCAM-1 (EC)!
a4f31 integrin (L) ligand pair in adhesive phenomena using HKEC. In
contrast to HKEC, the adhesion of U937 cells to HVC does not appear
to be primarily dependent on ICAM-l and VCAM-1. ELAM-l and
other cell adhesion molecules may be important in mediating leucocyte-
endothelial cell interactions in human vasculature. A further under-
standing of these mechanisms of cell adhesion between L and EC from
different vascular beds offers the prospect of differential pharmacolog-
ical manipulations of such interactions.
Effects of glucose, insulin and somatostatin on glomerular mesangial
cells (MC) to proliferate and produce collagen. C.G. Ihm, J.K. Park,
Department of internal Medicine, Kyunghee University, School of
Medicine, Seoul, Korea. Glomerular MC produce extracellular matrix
(ECM) components such as collagen, the dysregulation of which may
be related to the development of mesangial expansion and glomerulo-
sclerosis. The most significant renal lesion of diabetic nephropathy is
mesangial expansion, largely due to the accumulation of ECM proteins.
However, the initiating mechanism causing the accumulation of ECM
remains uncertain. Also, it is controversial whether high glucose (HG)
or insulin deficiency exert the main effect. The mitogenic action of
insulin has been suggested to be a contributing factor in the pathogen-
esis of diabetic angiopathy. Thus, studies have been undertaken to
determine whether HG directly stimulates cultured rat MC to prolifer-
ate and produce collagen, and whether this effect can be modulated by
insulin and somatostatin. Also, the collagen synthesis of MC in medium
containing normal glucose (NG) and high insulin (HI, 3.3 x lO M) has
been investigated. Sixteen hour exposure to HG (450 mg/dl) reduced
['H] thymidine uptake by 27.4 15.4% (N = 5, P < 0.05), which was,
however, returned toward normal with l0 M insulin, above pharma.
cological concentration. Collagen production was measured by [3H] pro-
line incorporation during the 1st 24 hours. Collagen and non-collagen
production in cell layer and medium by MC were significantly increased in
cultures containing HG (N = 6, P < 0.05), and were not suppressed by
addition of HI. By contrast, collagen and non-collagen production in








Normal 3491 224 2783 214 30096 8016 21434 2432
control
HG 4053 324 3398 276 38188 7463k 28226 3067a
HG + HI 4313 48la 3583 579k 34416 6984 32406 1959
NG + HI 3426 321 2751 400 29210 4051 22994 2281
Data are expressed as mean so cpm/l X 10' cell.
a P< 0.05 vs. Normal control & NG + HI
Sb( 0 2 Weeks 4
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Also, there was a good correlation between collagen production and
insulin concentration below l0 M (r = 0.98, P < 0.05). However,
collagen production in cultures containing iO M insulin (above phar-
macological concentration) was not different from normal control.
Somatostatin (l0) suppressed the increased collagen production in
medium (16%, P < 0.05) and in the cell layer (9%, P < 0.05). These
results indicate that HG, rather than insulin deficiency, directly stimu-
lates the production of collagen and non-collagenous proteins by MC
and inhibits MC proliferation, which may be pathogenic in the devel-
opment of accumulation of ECM in diabetes. Moreover, these pro-
cesses may be prevented in vivo if plasma glucose levels can be
normalized with initial high insulin dose, while hyperinsulinemia may
aggravate it in the state of hyperglycemia. Also, these effects may be
mitigated by administration of somatostatin.
Influence of TGF-$1 on fibronectin synthesis and splice patterns in
cultured human mesangial cells. N.G. McKay, N.E. Haites, D.A.
Power, Departments of Medicine and Therapeutics and Molecular and
Cell Biology, University of Aberdeen, Scotland, United Kingdom.
Fibronectin has been shown to accumulate in human mesangial prolif-
erative glomerulonephritis, probably due to secretion by the mesangial
cells. Transcription and translation of the fibronectin gene by various
cultured cells is reported to be increased in response to stimulation with
transforming growth factor beta (TGF-/31). Since there is evidence to
suggest that TGF-/31 is involved in the pathogenesis of experimental
mesangial proliferative glomerulonephritis, we have attempted to de-
termine the effect of recombinant TGF-131 on fibronectin synthesis by
cultured mesangial cells. In both cycling and growth arrested stimulated
human mesangial cells there was an initial (0—30 mm) decrease in the
fibronectin mRNA detected by Northern hybridization relative to
non-stimulated controls, followed by an increase over the next 24
hours. These data were supported by studies of fibronectin protein
secretion into the matrix and supernatant by ELISA and Western blots.
It is also apparent that most of the increase in fibronectin occurred in
the cells and matrix, rather than in the culture supernatant. Alternative
splicing of the primary fibronectin gene transcript at three splice sites,
(ElBA, EIIIB and IIICS), can lead to production of up to 20 different
mRNAs. Most of these splice sites involve the IIICS domain, which can
both introduce two additional glycosylation sites and function as a
ligand for cell surface receptors. To determine whether the increased
incorporation of fibronectin into the matrix might be associated with
differences in fibronectin splicing, we have designed and synthesised
two sets of oligonucleotide primers which bind 5' and 3' of the EIIIA
and IIICS splice sites. Using the polymerase chain reaction (PCR) we
are now analyzing the effects of TGF-j31 on the splicing pattern of
fibronectin RNA. These data may offer an explanation for the apparent
preferential incorporation of fibronectin into the extracellular matrix.
Collagen synthesis and gene expression of human renal fibroblasts in
vitro derived from kidneys with interstitial fibrosis. GA. Muller, H.P.
Rodemann, Medical University Clinic, University of Tubingen, Tübin-
gen, and Developmental Biology Units W7 and SFB 223, University of
Bielefeld, Bielefeld, Germany. The progression of inflammatory and
noninflammatory renal diseases depends often on the occurrence of
tubulointerstitial changes, especially on the severity and extension of
renal interstitial fibrosis (RIF) as shown by morphometric and immu-
nohistochemical analysis. Recently we have shown that renal fibro-
blasts from human kidneys with RIF (FKIF cells) are characterized by
hyperproliferative growth in primary clonal cultures and that these cells
exert significant alterations in the pattern of differentiation. Collagen
synthesis of mitotic (MF) and spontaneously developing postmitotic
(PMF) type cultures of renal fibroblasts derived from biopsies with RIF
(FKIF cells) and without RIF (NKF cells) were analyzed by the
incorporation of 3H-proline into pepsin-resistant protein. FKIF cells in
the mitotic as well as in the postmitotic phase synthesized about 3 to 5
times more total collagen than NKF cells. Postmitotic FKIF cells
produced about 1.6 times more total collagen than MF type cells. The
relative proportions of the three collagen types, synthesized by renal
fibroblasts differed significantly between NKF and FKIF cells. MF-
type FKIF cells synthesized only 86% collagen type I compared to the
97% of NKF cells. However, the amount of collagen type III and type
V produced by FKIF cells was enhanced 8 times (collagen type Ill) and
3 times (collagen type V). Furthermore, analysis of gene expression
revealed that only FKIF cells express a protein with a molecular mass
of 53 kDa and an isoelectric point of 6.1 (p53/6.1) which was therefore
named fibrosin. Further analyses are currently being performed to
identify the FKIF-specific protein fibrosin and to analyze the cellular
interactions between tubular epithelial cells and renal fibroblasts.
Stereological estimation of glomerular basement membrane material in
the early phase of diabetic nephropathy. R. 72sterby, H.-J. Bangstad,
K.J. Berg, K. Dahl-J$rgensen, K.F. Hanssen, A. Hartman,G. Nyberg,
University Institute of Pathology, Kommunehospitalet, Arhus, Den-
mark; Pediatric and Medical Department, Aker University Hospital,
Medical Department B, Rikshospitalet, Oslo, Norway; Transplant
Unit, Sahlgrenska Hospital, Goteborg, Sweden. Diabetic glomerulop-
athy is characterized by basement membrane (BM) accumulation:
thickening of the peripheral BM and expansion of mesangial regions
with matrix accumulation. In advanced stages the structural changes
are associated with overt nephropathy. The detection of early changes
in the mesangial regions is hampered by a large variation among cases
in the estimator, mesangial volume fraction, V(mes/glom). The
present results concern young insulin dependent diabetic patients
(IDDM) at the stage of incipient nephropathy, defined by slightly
elevated albumin excretion ("microalbuminuria"). With the aim of
improving the V(mat/glom) estimation serial sectioning was performed
and estimates obtained in 3 profiles, 60 apart, in each of 3 glomeruli.
BM thickness, matrix volume fraction, V(mat/glom) and matrix vol-
ume fraction of total BM material, V(matItot.BM), were estimated
from one level per glomerulus. From the serial sectioning the volume of
individual glomeruli was also obtained, enabling the estimation of total
volumes per glomerulus of matrix, V(mat). The analysis has been
completed in 10 IDDM patients. Reference data (not based on serial
sectioning) were obtained from 8 non-proteinuric kidney donors (KD).









BMT, nm 580 0.10 326 0.10 5 l0—
V (mes/glom) 0.22 0.09 0.20 0.15 0.19
Vj,, (mat/glom) 0.13 0.13 0.10 0.29 0.038
V.,, (mat/toi.BM) 0.56 0.11 0.59 0.10 0.42
V(mat), 0.75 0.32 0.22 0.47 3 l05
Conclusions: Diabetic patients with incipient nephropathy present a
marked BM accumulation which seems to involve the BM in capillary
walls and the mesangial matrix to the same extent.
Production of monoclonal antibodies to stimulated mesangial cell
matrix. D.A. Power, A. Mukhtar, MC. Jones, Department of Medicine
and Therapeutics, Aberdeen Royal Infirmary, Aberdeen, Scotland,
United Kingdom. The importance of cytokines in the pathogenesis of
mesangial proliferative glomerulonephritis is unclear, despite evidence
of extensive cytokine responsiveness and autocrine production of
cytokines in vitro. To detect the action of cytokines in vivo, we have
attempted to produce monoclonal antibodies which react with proteins
secreted de novo into the extracellular matrix (ECM) by cultured
mesangial cells following cytokine stimulation. ECM was obtained from
cultured mesangial cells stimulated with phorbol ester or IL-I and used
to immunize mice. Hybridomas were produced and screened by dot
blot assay using ECM from stimulated and non-stimulated cells; those
hybrids which reacted with ECM from stimulated cells alone were
chosen for further study. Six separate antibodies were obtained which
reacted with ECM and cultured mesangial cells only after stimulation.
The antigen detected by one of these, MPI5/84, is synthesized in
response to all cytokines tested (EGF, PDGF, IGF-1, IL-I, IL-6, FGF,
TGF-13), in response to low concentrations of IL-I (0.5 to 1.0 p/mI) and
within 15 mm. of stimulation. The antigen was not present in cycling
cells grown in FCS but required both gene transcription and translation
for expression. The choriocarcinoma cell line BeWo expressed it
constitutively but a variety of other transformed and normal cell types
did not. MPI5/84 detected three bands of Mr 161, 128 and 97 kD on
Western blots; the Mr was identical on reduced and non-reduced gels.
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The antigen was expressed in kidneys with IgA nephropathy and
membranous glomerulonephritis but not in normal kidneys or in a
number of normal tissues. These studies suggest that novel extracellular
matrix proteins are produced in glomerulonephritis, perhaps in re-
sponse to cytokine stimulation.
Thrombospondin and other matrix proteins modulate macrophage
uptake of senescent neutrophils undergoing apoptosis. J. Savill, N.
Hogg, and C. Haslett, Department of Medicine, Royal Postgraduate
Medical School, and Imperial Cancer Research Fund, London, United
Kingdom. Neutrophils (PMN) and their contents mediate tissue injury
in inflammation of the kidney and other organs. Clearance of PMN is a
prerequisite of the resolution of inflammation; an important clearance
mechanism is phagocytosis by macrophages (MØ) of intact senescent
PMN, which is determined by apoptosis (programmed cell death) in the
aging PMN, a process characterized by endogenous endonuclease
activation. These mechanisms are relevant to the kidney since cells
with characteristics of apoptotic neutrophils have been reported in
histological studies of glomerulonephritis (GN). Phagocytosis of apop-
totic PMN is mediated by the MØ aI33 integrin or "vitronectin
receptor" (VnR), being specifically inhibited by Arg-Gly-Asp (RGD)-
bearing peptides, and mAbs to both VnR subunits. Inhibition by amino
sugars and basic amino acids suggested that thrombospondin (TSP)
might play a role in MØ recognition of apoptotic PMN, since the same
molecules inhibit TSP-dependent adhesive properties of activated plate-
lets; furthermore, TSP is a candidate ligand for the VnR. MØ phagocy-
tosis of aged PMN (but not of IgG-opsonized ox red cells, EIgG) was
modulated by TSP. Inhibition by over 70% was observed with attach-
ment of MØ to TSP-coated surfaces prior to interaction with aged PMN,
or inclusion in the interaction medium of soluble protein at 100 jtg/ml,
as had been observed with vitronectin (Vn) and fibronectin (Fn) but not
other RGD-bearing proteins such as fibrinogen and type IV collagen. By
contrast with Vn and Fn, lower concentrations of soluble TSP (of the
order of 5 g/ml) enhanced aged PMN uptake (to 155 2.8% C [% of
control SEMI, N = 10) whether included in the interaction, or
preincubated with either cell type prior to interaction. This suggested
that TSP might modulate the interaction by acting as a "molecular
bridge" between aged PMN and a/33, a possibility supported by
specific inhibition of aged PMN uptake by: (i) mAbs to TSP (45.5
4.6% C, N = 11); (ii) mAbs to CD36, an 88kD MØ surface molecule with
controversial roles in adhesion to TSP, whether 1gM (SM 0; 22.1 3.1%
C, N = 11) or IgG (CiMegi; 41.4 5.3%, N = 5); and (iii) combination
of mAbs to CD36 and VnR, when synergistic effects were observed.
Furthermore, TSP was able to support adhesion to both apoptotic PMN
and to MØ. It is proposed that TSP may act as a molecular bridge
between aged PMN and MØ, where it binds to both CD36 and VnR.
These data indicate that at the inflamed site matrix components may
regulation MØ clearance of apoptotic PMN, a process which may limit
inflammatory tissue injury.
Effect of protein intake on intraglomerular proteinases. R.M.
Schaefer, S. Huang, M. Teschner, A. Heidland, Department of
Nephrology, University Wdrzburg, Würzburg, Germany. Recent stud-
ies suggest that proteinases are involved in the degradation of extracel-
lular matrix components of the renal glomerulus. In the present study
the effects of 3 different protein diets (casein: 5%, 20% and 60%, made
isocaloric by starch) on glomerular cysteine- and metallo-proteinase
activities in healthy rats were studied after 8 weeks. Upon sacrifice
glomeruli were isolated by differential sieving. Cysteine and metallo-
proteinase activities were measured using fluorogen substrates. Kidney
weight was closely correlated with the amount of protein ingested (5%:
1625 320; 20%: 2110 320; 60%: 2075 910 mg). Cathepsin L, the
most abundant proteinase in the glomerulus, decreased with protein
loading (5%: 297 30; 20%: 152 42; 60%: 87 11 pmol/min/tg
DNA). The same pattern emerged for cathepsin B (5%: 98 7; 20%: 65
5; 60%: 43 4 pmol/min/g DNA) and cathepsin H activities (5%: 87
5; 20%: 51 5; 60%: 31 4 pmol/min/pg DNA). The activity of the
metallo-proteinase collagenase decreased with high protein diets (5%:
233 14; 20%: 189 13; 60%: 137 11 pmol/min/g DNA). Gelatinase
activity displayed a similar tendency without reaching significance.
These findings suggest that glomerular proteinase activities can be
manipulated by the amount of protein ingested. This in turn may
represent a new mechanism by which protein restriction protects from
progressive renal failure.
Cultured glomerular mesangial and epithelial cells express mRNA
encoding the 72 kDa type IV collagenase, TIMP and TIMP-2. A. Sharma,
M. Kleppel, V. Kim, A. Michael, Department of Pediatrics, University
of Minnesota, Minneapolis, Minnesota, USA. The glomerular base-
ment membrane (GBM) and mesangial matrix are the principle struc-
tural elements of the glomerulus. This extracellular matrix Consists
primarily of type IV collagen in association with lesser amounts of other
matrix components. Expansion of mesangial matrix is a central event in
a number of human glomerular pathologies, including diabetic nephrop-
athy, IgA nephropathy, mesangial proliferative glomerulonephritis, and
focal and segmental glomerulosclerosis. Presumably, this represents
the cumulative effects of an imbalance between matrix synthesis and
degradation. However, relatively little is known about the pathways
involved in matrix degradation in normal or disease states. Although
metalloproteases capable of degrading type IV collagen have been
identified in culture supernatants of glomerular mesangial and epithelial
cells, their precise relationship to the recognized collagenases and
inhibitors has not been described. The purpose of this present study
was to determine the relationship between the type IV collagenolytic
and inhibitory activity described in cultured human mesangial and
glomerular epithelial cells and the known human type IV collagenases
and metalloprotease inhibitors. Human fetal mesangial cells and gb-
merular epithelial cells were grown in culture from explanted glomeruli.
Using specific cDNA probes to examine total cellular RNA for presence
of specific message, we have determined that cultured human mesangial
and glomerular epithelial cells express mRNA for the 72 kDa type IV
collagenase previously characterized from cultured human fibroblasts
and several tumor cell lines. Messenger RNA coding for tissue inhibitor
of the metalboproteases (TIMP), a glycoprotein inhibitor of all mamma-
lian metalloproteases, and an independently regulated inhibitor of
metalloproteases known as TIMP-2 were also found. Message for the
larger 92 kDa type IV collagenase was not detected in this preparation.
Analysis of RNA from human renal cortex indicates that the 72 kDa
enzyme and its inhibitors are also expressed in vivo, suggesting that this
system does play a role in matrix remodelling in the normal human
kidney. Further work to clarify the role of this matrix degrading enzyme
and its inhibitors in glomerular pathology is in progress.
Cloning of the Goodpasture antigen, the a3 chain of type IV collagen.
N. Turner, P.J. Mason, R. Brown, A.J. Rees, C.D. Pusey, Depart-
ments of Medicine and Hematology, Royal Postgraduate Medical
School, and Imperial Cancer Research Fund, London, England,
United Kingdom. The anti-glomerular basement membrane antibodies
which characterize and define Goodpasture's disease are known to be
directed towards a tissue-specific component of the C-terminal, non-
collagenous (NC 1) domain of type IV collagen, probably a new type IV
collagen chain (a3) identified by protein sequencing. We have obtained
amino acid sequences from tryptic and cyanogen bromide peptides of
the antigenic molecule isolated from sheep glomerular basement mem-
brane, and used them to amplify sheep kidney eDNA sequences
encoding the C-terminus of a new type IV collagen chain. This
sequence was then used to obtain cDNAs encoding the new chain from
a human cDNA library and by further polymerase chain reaction
amplifications. The sequences obtained spanned the entire 232 amino
acids of the NC1 domain of a new type IV collagen chain and included
108 amino acids from the collagenous region. The derived sequence was
closely similar to protein sequence from the bovine a3 chain in the
region of the NC 1/triple helical junction, and to the recently described
bovine a3 cDNA. It included sequences predicted from the peptides
obtained from sheep kidney, and has a high content of basic amino
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acids, explaining its strongly cationic nature on two dimensional
electrophoretic analysis. Northern blotting studies show that the a3
chain is expressed in kidney and lung but scarce or absent in most other
tissues. Interestingly, the COL4A3 gene maps to chromosome 2,
excluding a direct role for the chain in most cases of Alport's syndrome.
Binding to microvascular endothelial cells and selected extracellular
matrix components is modulated by differential expression of cell surface
integrins on CD4-I-, CD45RA— Thi (inflammatory) and Th2 (helper)
lymphocytes. G. Zimmerman, C. Pfeffer, K. Bottomly, J.A. Madri,
Departments of Pathology and Immunology, Yale University School of
Medicine, New Haven, Connecticut, USA. In the processes of normal
lymphocyte homing and during inflammation the initial step of lympho-
cyte migration is adhesion to endothelial cells via specific homing
receptors, including the integrin a413p. Following transmigration, the
lymphocytes come into close contact with the subendothelial and
interstitial matrix. Lymphocyte adhesion to fibronectin, laminin and
collagen has been shown to be integrin-dependent and variable, depend-
ing upon the state of the lymphocytes (naive vs. memory vs. activated).
Our investigations of two functionally-different CD4+, CD45RA—
cells, Thi (inflammatory lymphocytes which suppress B-cell function
and antibody production, and mediate delayed-type hypersensitivity
responses, and kill appropriate target cells) and Th2 (helper cells which
provide specific and polyclonal B-cell responses) revealed differential
binding patterns to cultured microvascular endothelial cells and se-
lected extracellular matrix components [Fibronectin (Fn), Laminin (Ln)
and type IV collagen (IV)I and differential expression of cell surface f3l
integrins. Specifically, ThI cells exhibited strong binding to rat micro-
vascular endothelial cells cultured in two-dimensional and three-dimen-
sional cultures, while Th2 cells exhibited weak binding. In addition to
endothelial cell adhesion, Thi and Th2 cells were tested for their
potential to bind to the matrix components Fn, Ln and IV. Thi cells
exhibited high binding to IV (60%), moderate binding to Fn (30%) and
low binding to Ln (10%). In contrast, Th2 cells exhibited modest
binding to IV and Fn (30%) and low binding to Ln (10%). The Fn
binding was further investigated using fusion peptides containing alter-
natively-spliced IIICS regions, plus/minus the RGD domain. These
studies revealed equal Thi binding to IIICS and RGD domains while
Th2 cells bound only to RGD domains, suggesting differential expres-
sion of j31 integrins, specifically, a4j31. Thl and Th2 cell surface
matrix-binding proteins were isolated and characterized using affinity
chromatography on Fn- and IV-Sepharose columns and immunoprecip-
itation with (31-specific and a2-, cs3-, a4- and aS-specific antibodies.
Results illustrate the presence of increased amounts of j3l integrins on
Thi cells compared to Th2 cells. These studies illustrate the importance
of (31 integrins in the modulation of lymphocyte subset binding to
endothelia and matrix components.
Mesangial cell extracellular matrix glycoprotein synthesis is not inhib-
ited by cell-cell contact. M.J. Adcox, C.K. Abrass, University of
Washington, Seattle, Washington, USA. The glycoproteins fibronectin,
laminin and entactin constitute the dominant noncollagenous proteins
of the glomerular mesangial matrix. Since mesangial cell proliferation
often precedes the development of glomeruloscierosis and evidence
exists that cell-cell contact may be important in the regulation of matrix
components we have studied the effect of cell-cell contacts and conflu-
ency upon extracellular matrix glycoprotein synthesis. In vitro mesan-
gial cells were analyzed for de novo laminin and fibronectin synthesis by
radioimmunoprecipitation. In addition, laminin accumulation was doc-
umented by the use of a laminin specific ELISA. Our results demon-
strate that the laminin-entactin complex is recoverable form both the
cell layer and cell supernates of mesangial cells in culture. In both the
cell layer and cell supernates protein bands at 230 kD (B1), 220 kD (B2)
and 150 kD (entactin) were quite prominent while the 400 kD (A) band
was less obvious. This detection of the laminin-entactin complex
occurred in both cells sparsely plated and those just allowed to reach
confluency before labelling, and in cells densely plated prior to label-
ling. In a similar fashion fibronectin was recoverable in both the cell
layer and cell supernates. Qualitatively fibronectin was most notable in
the cell supernates as compared to the cell layer. De novo fibronectin
synthesis was observed in cells both sparsely and densely plated.
Furthermore, cells plated at sparse and dense numbers were allowed to
proliferate, and serial determinations of soluble laminin as detected by
ELISA were established. Laminin continues to accumulate in cell
culture supernates despite the establishment of cell-cell contacts and
high-density culture conditions. In conclusion our results suggest that
de novo extracellular matrix glycoprotein synthesis continues after the
development of cell-cell contacts and that these matrix components
accumulate over time.
Influence of heparin, dexamethasone, glucose and LDL on basement
membrane heparan sulfate proteoglycan synthesis. E. Schleicher, B.
OlgemOller, S. Schwaabe, E. Wagner, K.D. Gerbitz, Inst. for Clinical
Chemistry and Diabetes Research, Schwabing City Hospital,
Mhnchen, Germany. The synthesis of basement membrane-associated
heparan sulfate proteoglycan (HSPG) was studied in proliferating
cultures of endothelial cells derived from porcine aorta. HSPG was
quantitated by enzyme immunoassay using an antiserum developed
against HSPG from glomeruli. The antibodies specifically recognize the
core protein of HSPG from vascular basement membranes. Increasing
heparin concentrations diminished HSPG content of the cultures by
60%. The effect of heparin was specific since fibronectin synthesis as
well as metabolic activity and cell proliferation as assessed by lactate
production and DNA content were not affected. The influence of
heparin was antagonized by dexamethasone which normalized HSPG
content to control values. TGF-(3 inhibited 3H-thymidine incorporation
by 50%, while HSPG synthesis was simultaneously increased. LDL
decreased HSPG synthesis in a concentration-dependent manner in
cultured porcine endothelial cells and in mesangial cells, whereas
fibronectin synthesis was not affected. Glucose exerted an inhibiting
effect on HSPG synthesis in mesangial cells, while no effect could be
found in endothelial cells. Our results indicate that HSPG synthesis is
regulated individually by metabolic and humoral factors, although the
underlying mechanism is not yet understood.
Differential expression of tenascin isoforms during mouse kidney de-
velopment. S. Beck-Gessert, A. Weller, P. Ekblom, Medizinische Uni-
versitatsklinik, Tubingen and Max-Planck-Institut für Immunbiologie,
Freiburg, Germany; Uppsala University, Uppsala, Sweden. Tenascin
is a mesenchymal extracellular matrix glycoprotein with a specific
spatially- and temporally-restricted tissue distribution. In the embry-
onic kidney it is selectively expressed in the mesenchyme surrounding
growing kidney tubule epithelia. We have isolated eDNA clones cov-
ering the complete coding sequence of mouse tenascin and analyzed the
expression of tenascin mRNA. Northern hybridizations show two
different mRNAs, 6 and 8 kb in length, which are differentially
expressed. The 8 kb mRNA is more prominent than the 6 kb mRNA
throughout prenatal kidney development, but during postnatal devel-
opment the ratio of the two mRNA changes. The Northern hybridiza-
tions and sequence data suggest that the two major mouse tenascin
polypeptides arise through an alternative RNA splicing. The deduced
amino acid sequence shows a modular structure of cysteine-rich repeats
with similarity to the type III repeat of fibronectin. The different
splicing variants contain different numbers of the fibronectin type III
repeats. The suggested splicing site is located directly after the fifth type
III repeat. In human and chicken tenascin the third type III repeat
contains the tripeptide RGD, which has been suggested to be involved
in cell binding. In contrast to chicken and human sequences, mouse
tenascin contains an RVD sequence instead of an RGD sequence in the
third type III repeat. It's commonly appreciated that binding regions are
highly conserved structures during evolution. Therefore, we suggest
that this tripeptide ROD in the tenascin molecule is not involved in cell
binding.
Effect of cyclosporine on laminin expression in the rat kidney. A.
Artishevsky, 5G. Adler, R.J. Glassock, C.C. Nast, Harbor-UCLA
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Medical Center, Torrance, California, USA. Laminin is a ubiquitous
glycoprotein present in tubular and glomerular basement membranes,
Bowman's capsule, as well as the mesangium. We studied whether
alterations in laminin occur in cyclosporine nephrotoxicity, a condition
characterized by cortical interstitial fibrosis and tubular atrophy. Ex-
perimental evidence points to a possible involvement of procollagen
al(l) mRNA in this pathological process. In this study, we examined
the effects of cyclosporine on the levels of laminin Bl mRNA and
protein assessed immunohistochemically in rats to ascertain the relative
contribution of laminin to the cyclosporine induced fibrosis. In control
rats, Northern blot data indicate that laminin B I mRNA is preferentially
expressed in the renal cortices as compared to the medullary tissue.
Analogous results in renal tissue from control and cyclosporine injected
rats showed laminin to be more predominant in cortical compared to
medullary tubules. Cyclosporine administration caused focal interstitial
fibrosis and tubular atrophy/basement membrane thickening by 4 weeks
with increases in procollagen al(1) mRNA at 1 and 4 weeks. The levels
of laminin B I mRNA are not altered after I and 4 weeks of cyclosporine
administration despite the evidence of fibrosis at 4 weeks. Thus,
message for laminin BI chain is produced most abundantly in cortical
rat tissue. Furthermore, the amount of laminin B I mRNA remained
unchanged under the conditions of tubulointerstitial and cortical fibrosis
caused by cyclosporine administration.
Use of quantitative polymerase chain reaction (PCR) to estimate
fibronectin transcript numbers in cultured mesangial cells. N.E. Haites,
N. McKay, D.A. Power, Departments of Molecular and Cell Biology
and Medicine and Theraputics, University of Aberdeen, Aberdeen,
Scotland, United Kingdom. Firbonectin accumulates within the gb-
merular mesangium in patients with a variety of glomerular lesions and
contributes to loss of the glomerular space in these diseases. Fibronec-
tin occurs in two major forms: (I) plasma fibronectin (a soluble form)
which is smaller than (2) cellular fibronectin (a cell surface associated
form) due to alternative splicing of the primary transcript. Within the
glomerular mesangium we have found that the plasma form appears to
predominate by immunohistochemistry in both the normal and diseased
kidney. To study the factors that lead to increased synthesis of
fibronectin and which may control alternative splicing, we have devel-
oped a method for quantitative estimation of mRNA transcripts for
fibronectin using, as an internal control, a modified cDNA of fi-
bronectin. Three regions of alternative splicing exist, two of which
consist of the splicing in or out of one type III segment (EDIIIA and
EDILIB). We have been studying splicing varients EDIIIA+ and
EDILIA—. So far, we have found that cycling mesangial cells produce
approximately 2467 EDIIIA— and 1330 EDIIIA+ fibronectin tran-
scripts per ng of mRNA or approximately 3 copies of EDIIIA— and 1.6
copies of EDIIIA+ fibronectin mRNA per cell, with a coefficient of
variation for the assays of 10% and 14%, respectively. This assay is the
most sensitive so far described for the detection of small changes in
mRNA species, and should allow the influence of cytokines on mesan-
gial cell fibronectin gene transcription and splicing to be determined
witt, great accuracy.
Leukocyte adhesion to and transmigration across endothelia. M. Ga/l-
atin, Hutchinson Cancer Research Center, Seattle, Washington, USA.
Movement of leukocytes from the bloodstream across endothelium
occurs in a stepwise fashion, with each step (such as, attachment,
lateral movement) facilitated by distinct sets of cell adhesion molecules.
We have studied these lymphocyte-endothelial cell interactions in vitro
using cultured human umbilical vein endothelial cells (HUVEC) or
early passage microvascular EC from the pig-tailed macaque (Macaca
nemestrina) and human or macaque peripheral blood lymphocytes
(PBL). By combining a three-dimensional culture system with analyses
by laser scanning confocal microscopy, the topographical reorganiza-
tion and roles of specific cell adhesion molecules (CAMs) during the
transmigration process were examined. Reorganization of some (CD44,
CD45R, LECAM-l) but not other (LFA-1) PBL surface adhesion
molecules into extending processes was observed, an event which was
specifically triggered by PBL-EC contact and was accompanied by
cytoskeletal redistribution. In some cases (such as, LECAM-l) selec-
tive movement of CAM isoforms within the plasma membrane was
observed. Secondary CAM movement was determined in part by the
qualitative nature of initial EC-lymphocyte contact. Cytoskeletal reor-
ganization was also apparent in EC after co-culture with PBL and may
reflect fenestration in some of these cells. Cytoskeletal contributions to
lymphocyte shape change and membrane molecule redistribution, and
to the EC contact dependence of these events, were investigated using
cytoskeleton-disrupting drugs. We observed differential sensitivity in
the reorganization of various cell surface adhesion molecules to micro-
tubule and microfilament destabilizing agents. The implications of these
findings for migration of virgin and memory T-cells will be discussed in
the context of organ-selective cell traffic.
DNA sequences that confer tissue specific expression to a type I collagen
gene. B. de Crombrugghe, H. Goldberg, T. Helaakoski, G. Karsenty,
K. Niederreither, Department of Molecular Genetics, The University of
Texas M. D. Anderson Cancer Center, Houston, Texas, USA. Type I
collagen is a heterotrimeric molecule consisting of two a! chains and
one a2 chain. High levels of RNA for both the al and a2 chains are
found in tendons, bones and skin and much smaller levels in a number
of other organs. Increased levels of type I collagen and type I collagen
RNA are found in fibrotic lesions. Experimentally in cultured fibro-
blasts, cytokines such as TGF-/3 and IL-I lead to increased levels of
type I collagen RNA. We have sought to determine the minimal DNA
segment in the 5' flanking sequences of the mouse a2(I) collagen gene
needed to confer tissue-specificity. We generated transgenic mice
harboring chimeric genes containing either 2000 bp or 350 bp of DNA
sequences upstream of the start of transcription of the a2(I) collagen
gene fused to the chioramphenicol acetyl transferase gene, or 220 bp
fused to the luciferase gene. With the 2000 bp construction tissue
specificity was almost identical to that of the endogenous gene, whereas
with the 350 bp construction a similar tissue specificity was found
except for the anomalous expression of the transgene in brain. With the
220 bp construction a similar considerable degree of tissue specificity
persisted. We have identified several different proteins which bind to
specific sites in the a2(l) collagen promoter between 60 and 350 bp
upstream of the start of transcription. Three of these proteins, which
are activators of transcription, and the one inhibitory factor, appear to
be failrly ubiquitously distributed in different cell types. Transient
expression experiments using either the 350 bp or the 220 bp constructs
in DNA transfections show expression in both fibroblasts and B cells,
whereas the endogenous a2(I) collagen gene is active only in fibroblasts
and completely silent in B cells. However, similar transfection experi-
ments with chimeric genes containing selected 30 bp DNA fragments,
chosen within the 220 bp DNA upstream of the start of transcription,
and amplified upstream of a minimal promoter, showed much greater
activity in fibroblasts than in B cells. These DNA fragments are binding
sites for factors which display much higher DNA binding activity in
extracts from fibroblasts than in extracts from B cells. These factors
might confer tissue specificity to the type I collagen genes.
Regulation of collagen IV gene transcription. P.D. Ku/en, University
of Michigan, Department of Pathology, Ann Arbor, Michigan, USA.
The renal glomerulus has a relatively limited repertoire of responses to
injury. Chronic glomerular injury, whether immunologic, hemody-
namic, or metabolic in origin, leads to pathological accumulations of
extracellular matrix-glomerular sclerosis. This process is widely con-
sidered irreversible and inexorable, leading to permanent organ dys-
function or organ failure. Collagen IV, the principal structural compo-
nent in glomerular matrices, is thought to provide tensile strength and a
scaffold for the assembly of other basement membrane components.
The most abundant collagen IV chains in the glomerular basement
membranes are the al(IV) and a2(IV) chains. Expression of these genes
is highly regulated in space and time. Steady-state mRNA levels
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increase during early nephronogenesis peaking 1 week after birth, when
nephron number is fixed. Subsequently, the mRNA for these chains fall
to less than 10% of maximum during adult life. Experimental models of
glomerulonephritis demonstrate marked increases in the steady state
level of collagen IV mRNA prior to the development of morphological
evidence of sclerosis. The mediators of this response are being defined.
TGF-J3, a potent cicatricial mediator implicated in the pathogenesis of
these glomeru-lonephritides, causes a significant increase in collagen IV
mRNA by glomerular rnesangial cells. This appears to be due princi-
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pally to an increase in transcription of the al(IV) and a2(IV) genes. The
genes encoding the al(tV) and a2(IV) chains are separated at their 5'
ends by a 130 bp bidirectional promoter, which is regulated by se-
quences dispersed within the structural genes. Some of these sequences
have been identified and shown to regulate the collagen IV or viral
promoters in a cell- and tissue-specific fashion, Nuclear extract proteins
bind these sequences specifically and correlate with transcription of the
genes. The mechanism of TGF-/3-induced collagen IV transcription
remains to be elucidated.
